Messevorstellungen - 500 Beiträge pro Seite

[Popeye82]

explizit TOTAL anpruchsloser Thread.
wer Niveau sucht bitte SOFORT die Nachmittagssendungen einschalten.

geht hier nur um ein paar Links von AGs die sich (auf Messen?)vorstellen,
wenn es geht noch ein bisschen Beschreibung dazu,
diesen.
im Optimalfall wären noch die "casts"((vor Ort)Präsis), oder sowas, dazu einstellbar.


hier die ERSTEN Looser,
die um Aktionärsgelder buhlen.
und dafür WAHRSCHEINLICH Ihre Oma verkaufen:
http://conferences.networknewswire.net/2016/ld-micro/main-ev…

[Popeye82]

Antwort auf Beitrag Nr.: 53.838.989 von Popeye82 am 06.12.16 18:50:31

Korrektur.
die Frage soll nicht OmaS, sondern Oma heissen.
also verdoppeln sich die Preise

[Popeye82]

Antwort auf Beitrag Nr.: 53.838.989 von Popeye82 am 06.12.16 18:50:31

ein paar von watch:

"Lantronix, Inc. (LTRX) Akers Biosciences, Inc. (AKR) InspireMD, Inc. (NSPR) Limbach Holdings (LMBH)
8:00 Pointer Telocation Ltd. (PNTR) Ooma, Inc. (OOMA) NeuroMetrix, Inc. (NURO) Uniroyal Global Engineered Products, Inc. (UNIR) Capstone Turbine Corp. (CPST)
8:30 Orion Energy Systems (OESX) PixarBio (PXRB) Oculus Innovative Sciences (OCLS) Resonant, Inc. (RESN) Ur-Energy, Inc. (URG)
9:00 Issuer Direct Corp. (ISDR) inTEST Corp. (INTT) Spotlight Innovation, Inc. (STLT) Advanced Medical Isotope Corp. (ADMD) Onconova Therapeutics, Inc. (ONTX)
9:30 Lightbridge Corp. (LTBR) New Age Beverages Corp. (NBEV) Hemispherx Biopharma (HEB) Citius Pharmaceuticals, Inc. (CTXR) BioCorRx (BICX)
10:00 PCM, Inc. (PCMI) Fusion Telecommunications (FSNN Ener-Core, Inc. (ENCR) IntelliPharmaCeutics International, Inc. (IPCI)
10:30 Ironclad Performance Wear (ICPW) Xtant Medical Holdings, Inc. (XTNT) U.S. Geothermal Inc. (HTM) Relmada Therapeutics (RLMD)
11:00 Auxilio, Inc. (AUXO) Data I/O Corp. (DAIO) Nano Dimension (NNDM) PURE Bioscience (PURE)
11:30 Aspen Group, Inc. (ASPU) Mitek Systems (MITK) Rosetta Genomics (ROSG) Gopher Protocol, Inc. (GOPH) Actinium Pharmaceuticals (ATNM)
12:00pm VolitionRx Ltd. (VNRX) Psychemedics Corp (PMD) TapImmune (TPIV) Cytori Therapeutics (CYTX) FTE Networks (FTNW)
12:30 Marathon Patent Group (MARA) IDW Media Holdings (IDWM) Socket Mobile, Inc. (SCKT) Perma-Fix Environmental Services (PESI) IsoRay, Inc. (ISR)
1:00 Westell (WSTL) Synacor, Inc. (SYNC) Dolphin Digital Media, Inc. (DPDM) The Alkaline Water Company, Inc. (WTER)
1:30 Social Reality, Inc. (SRAX) Ballard Power Systems, Inc. (BLDP) BG Staffing, Inc. (BGSF) Viking Therapeutics (VKTX) Spectra7 Microsystems, Inc. (SPVNF)
2:00 Digital Ally (DGLY) CV Sciences, Inc. (CVSI) Sysorex Global (SYRX) Hooper Holmes, Inc. (HH) SuperCom (SPCB)
2:30 Vuzix Corp. (VUZI) Global Self Storage (SELF) Hamilton Thorne Ltd (HTLZF) Memex (MENXF)
3:00 Acme United Corp. (ACU) NV5 Global, Inc. (NVEE) Omni-Lite Industries (OLNCF) The Singing Machine Company (SMDM)
3:30 SilverSun Technologies (SSNT) Kush Bottles, Inc. (KSHB) Ascendant Solutions (ASDS) Regenerx Biopharmaceuticals (RGRX) Trendlines Group (TRNLY)
4:00 Trecora Resources (TREC) Midwest Energy Emissions Corp. (MEEC) Micronet Enertec Technologies (MICT) Avant Diagnostics, Inc. (AVDX) Remark Media (MARK)
4:30 Autobytel, Inc. (ABTL) COPsync, Inc. (COYN) Snipp Interactive, Inc. (SNIPF) Pyxis Tankers, Inc. (PXS) Socket Mobile, Inc. (SCKT)"

[Popeye82]

Antwort auf Beitrag Nr.: 53.841.017 von Popeye82 am 06.12.16 22:37:36

Wednesday,
einige nicht 10.000%ig unbekannt,
und Eine im Bestand:

"S&W Seed Company (SANW) GWG Holding, Inc. (GWGH) ICTV Brands (ICTV) Fision Corp. (FSSN) Biomerica, Inc. (BMRA)
8:00 iCAD, Inc. (ICAD) Asterias Biotherapeutics (AST) Biocept, Inc. (BIOC) NovaBay Pharmaceuticals (NBY) Patriot One Technologies, Inc. (PTOTF)
8:30 Miramar Labs (MRLB) Check-Cap (CHEK) Bion Environmental Technologies (BNET) Gemphire Therapeutics, Inc. (GEMP) CAS Medical Systems (CASM)
9:00 Newtek Business Services (NEWT) Lakeland Industries (LAKE) Provision Holding (PVHO) Caladrius Biosciences, Inc. (CLBS) Charles & Colvard (CTHR)
9:30 Nephros, Inc. (NEPH) Zoned Properties, Inc. (ZDPY) Cemtrex Inc. (CETX) Valeritas Holdings (VLRX) Park City Group, Inc. (PCYG)
10:00 Finjan Holdings, Inc. (FNJN) Coffee Holding Company, Inc. (JVA) MagneGas Corp. (MNGA) Bridgeline Digital, Inc. (BLIN) Moleculin Biotech, Inc. (MBRX)
10:30 22nd Century Group, Inc. (XXII) iPass, Inc. (IPAS) BioLineRx Ltd. (BLRX) Tonix Pharmaceuticals Holding Corp. (TNXP) Heat Biologics (HTBX)
11:00 NAPCO Security Technologies, Inc. (NSSC) Xplore Technologies Corp. (XPLR) First Choice Healthcare Solutions, Inc. (FCHS) Ritter Pharmaceuticals, Inc. (RTTR) MassRoots, Inc. (MSRT)
11:30 Simulations Plus (SLP) BioSig Technologies, Inc. (BSGM) Akoustis Technologies, Inc. (AKTS) VBI Vaccines, Inc. (VBIV) Luna Innovations, Inc. (LUNA)
12:00pm WidePoint Corp. (WYY) Salem Media Group, Inc. (SALM) Delcath Systems, Inc. (DCTH) TheStreet, Inc. (TST)
12:30 GSI Technology, Inc. (GSIT) One Horizon Group (OHGI) Atossa Genetics, Inc. (ATOS) Optex Systems Holdings (OPXS)
1:00 Mobivity Holdings Corp. (MFON) Propanc Health Group Corp. (PPCH) Exactus, Inc. (EXDI) Function(x) Inc. (FNCX)
1:30 Tio Networks (TNCGF) Arch Therapeutics, Inc. (ARTH) Kindred Biosciences, Inc. (KIN) Inventergy Global, Inc. (INVT) Full House Resorts, Inc. (FLL)
2:00 RCI Hospitality Holdings, Inc. (RICK) Chanticleer Holdings (HOTR) MabVax Therapeutics Holdings (MBVX) CytoDyn, Inc. (CYDY) Youngevity International, Inc. (YGYI)
2:30 Second Sight Medical Products (EYES) Terra Tech Corp. (TRTC) RMG Networks Holding Corp. (RMGN) Relmada Therapeutics (RLMD) Inuvo, Inc. (INUV)
3:00 SharpSpring, Inc. (SHSP) GrowGeneration Corp. (GRWG) Cesca Therapeutics (KOOL) First Harvest Corp. (HVST) TrackX Holdings (TKXHF)
3:30 Sevcon, Inc. (SEV) Medovex Corp. (MDVX) Stellar Biotechnologies, Inc. (SBOT) Reign Sapphire Corp. (RGNP)
4:00 Sunworks, Inc. (SUNW) Medite Cancer Diagnostics (MDIT) OncoSec Medical Inc. (ONCS)
4:30 Cytosorbents Corp. (CTSO) Pioneering Technology Corp. (PTEFF) Genius Brands International, Inc. (GNUS) Flux Power Holdings, Inc. (FLUX) Xenetic Biosciences, Inc. (XBIO)
5:00 TESSCO Technologies, Inc. (TESS) NTN Buzztime, Inc. (NTN) Reed's, Inc. (REED)"

[Popeye82]

Antwort auf Beitrag Nr.: 53.841.083 von Popeye82 am 06.12.16 22:51:11

Thursday,
eine Kombination,
aus Schreiben 3 +4:

"Vitality Biopharma (VBIO) US Nuclear Corp (UCLE) Marina Biotech, Inc. (MRNA)
8:30 ClearSign Combustion Corp. (CLIR) Veru Healthcare (FHCO)
9:00 Bel Fuse, Inc. (BELFB) Signal Bay, Inc. (SGBY) Pressure Biosciences, Inc. (PBIO)
9:30 AstroNova, Inc. (ALOT) UGE International Ltd. (UGEIF) Theralase Technologies, Inc. (TLTFF) Aytu BioScience, Inc. (AYTU)
10:00 Amyris, Inc. (AMRS) BioLargo, Inc. (BLGO) Ecoark Holdings, Inc. (EARK)
10:30 Digirad Corp. (DRAD) Ideal Power, Inc. (IPWR) Sorrento Therapeutics, Inc. (SRNE) Celsius Holdings, Inc. (CELH)
11:00 Eastside Distilling, Inc. (ESDI) Nxt-ID, Inc. (NXTD)
11:30 MGT Capital Investments, Inc. (MGTI) Apricus Biosciences, Inc. (APRI)
12:00pm BIOLASE, Inc. (BIOL) MRV Communications, Inc. (MRVC) Gatekeeper Systems, Inc. (GKPRF)
12:30 Gold Standard Ventures Corp. (GSV) Greenwood Hall, Inc. (ELRN) Research Solutions, Inc. (RSSS) Uranium Resources, Inc. (URRE)
1:00 Sevcon, Inc. (SEV)"

[Popeye82]

Teilnehmerauszüge,
1 im Bestand:

www.mass-spec-capital.com/product/morgan-34th-annual-healthc…

"MannKind Corporation (NASDAQ: MKND) $290mn Mcap, ~$35.5mn in cash

Focused on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes
Launching Afrezza®, a disruptive technology for the treatment of diabetes using powdered insulin
Technosphere ® Clinical pipeline with 3 technologies; Epinephrine, Trepostinil, & Palonestron
For more information, please visit: www.mannkindcorp.com

Enumeral Biomedical Holdings (OTC-ENUM) ~$10mn Mcap

Bio-pharma company focused on discovering and developing novel antibody immunotherapies that help the immune system attack diseased cells
Unique platform allows for to identifying and characterizing promising new drugs relevant to cancer, infectious and inflammatory diseases
Developing two antagonist PD-1 antibodies, ENUM 388D4 and ENUM 288C4 for use in treating cancer
For more information, please visit: www.enumeral.com

Myomo (Private)

Myomo, Inc., is a medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company's products help to restore function in individuals with neuromuscular conditions such as brachial plexus injury, traumatic brain injury, spinal cord injury, multiple sclerosis, ALS, and stroke.
The Company's myoelectric orthoses have been clinically shown to help restore the ability to complete functional tasks by enabling individuals to self-initiate and control movement of their partially paralyzed limbs by using their own muscle signals.
The Myomo technology was originally developed at Massachusetts Institute of Technology in collaboration with medical experts affiliated with Harvard Medical School. Myomo, Inc. is a privately held company headquartered in Cambridge, MA.
For more infiormaiton, please visit: www.myomo.com

Abeona Therapeutics (NASDAQ: ABEO) $290mn Mcap, ~$75mn cash

Clinical stage bio-pharma company developing gene and plasma-based therapies for life-threatening rare genetic diseases
Lead programs are adeno-associated virus based gene therapies for Sanfilippo syndrome. Other programs include for recessive dystrophic epidermolysis bullosa, juvenile Batten disease, Fanconi anemia disorder
For more information, visit www.abeonatherapeutics.com

Actinium Pharmaceuticals (NYSE: ATNM) $57mn Mcap, ~$16mn cash

Bio-pharma company with proprietary platform that utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells
Lead programs product candidate for hematopoietic stem cell transplant. Ongoing pivotal Phase 3 clinical trial for R/R AML. Second product on Phase 2 for newly diagnosed AML
For more information, visit www.actiniumpharma.com

Arch Therapeutics (OTC: ARTH) $81mn Mcap, ~$6mn cash

Device company with novel approach to stop bleeding and control leaking during surgery and trauma care
Products under development leverage innovative self-assembling peptide technology
For more information, visit www.archtherapeutics.com

Asterias Biotherapeutics (NASDAQ: AST) $260mn Mcap, ~$34mn cash

Clinical stage immunotherapy and pluripotent stem cell platform programs in the fields of neurology and oncology
Phase 1/2a dose escalation in spinal cord injury; Phase 2 in AML; partnered Phase 1/2a in non-small cell lung cancer
For more information, visit www.asteriasbiotherapeutics.com

Aytu Bioscience (OTC: AYTU) $12mn Mcap, ~$11mn cash

Commercial-stage specialty pharma company with portfolio of novel urology products.
Revenue generating products include Natesto, the only-FDA approved nasel spray for low testosterone, an imaging specific PSMA for prostate cancer detection/staging, and a trimethoprim-only oral solution for urinary tract infections. Ongoing 510k clinical trial for a semen analysis system for male infertility caused by oxidative stress; product is commercial outside the US.
For more information, visit www.aytubio.com

BioLineRx (NASDAQ, TASE: BLRX) $60mn Mcap, ~$39mn cash

Clinical stage bio-pharma company dedicated to identifying, in-licensing and developing promising therapeutics
Immuno-oncology collaboration with Merck for pancreatic cancer and Genentech for pancreatic cancer, gastric cancer, non-small cell lung, maintenance AML. Three announced projects via Novartis collaboration for liver diseases/NASH/ESLD and dry eye syndrome. Commercial in Europe with OTC skin lesion product with Perrigo.
For more information, visit www.biolinerx.com

Catalyst Biosciences (NASDAQ: CBIO) $10mn Mcap, ~$49mn cash

Clinical stage bio-pharma company developing novel therapies for hematology indications
Next-gen coagulation Factor VIIa variant, marzeptacog alfa, completed intravenous Phase 1 clinical trial for severe hemophilia A or B
In advanced pre-clinical development for next-gen Factor IX variant
For more information, visit www.catalystbiosciences.com

Cellectar Biosciences (NASDAQ: CLRB) $12mn Mcap, ~$10mn cash

Developing phospholipid drug conjugates for targeted cancer delivery of diverse oncologic payloads
Lead therapeutic utilizing iodine-131 as payload currently in orphan designated Phase 1 clinical trial for R/R multiple myeloma
Pipeline includes paclitaxel
For more information, visit www.celectar.com

Check-Cap (NASDAQ: CHEK) $31mn Mcap, ~$13mn cash

Clinical-stage medical diagnostic company developing low dose x-ray based ingestible capsule for preparation free, minimally invasive colorectal cancer screening
Designed to increase willingness to participate in screening, addresses barriers such as laxative bowel preparation, invasiveness, sedation
For more information, visit www.check-cap.com

Champions Oncology (NASDAQ: CSBR) $20mn Mcap, ~$4mn cash

Developing TumorGraft technology platform to personalize cancer care based on implantation of primary human tumors in immune deficient mice to determine efficacy of drug/treatment regimen
Targeting two groups: Personalized Oncology Solutions and Translational Oncology Solutions for pharma/biotech companies
For more information, visit www.championsoncology.com

Cytori Therapeutics (NASDAQ: CYTX) $34mn Mcap, ~$15mn cash

Late stage cell therapy company developing autologous cell therapies from adipose tissue to treat variety of medical conditions
Three ongoing Phase 3 clinical trials: scleroderma hand disease in US and Europe and urinary incontinence in Japan
For more information, visit www.cytori.com

Inovio Pharmacueticals (NASDAQ: INO) $581mn Mcap, ~$120mn cash

DNA-based immunotherapy platform; advancing multiple cancer and infectious disease products
Lead product focused on cervical high-grade pre-cancer caused by HPV
Expanding portfolio of immune therapies; advancing pre-clinical and clinical pipeline; In collaboration with MedImmune, DARPA, UPenn, NCI, among others
For more information, visit www.inovio.com

Intellipharmaceutics Int’l (NASDAQ: IPCI) $90mn Mcap, ~$4mn cash

Specialty-Pharma company specializing in novel and generic controlled-release and targeted-release oral solid dosage drugs
Leveraging patented Hypermatrix technology, a multidimensional controlled-release delivery platform. Basket of FDA approved drugs and candidates in development
For more information, visit www.intellipharmaceutics.com

IsoRay (NYSE: ISR) $32mn Mcap, ~$14mn cash

Sole producer of Cesium-131 brachytherapy seeds; expanding brachytherapy options throughout the body
New management team has intense focus on driving revenue growth
For more information, visit www.isoray.com

Moleculin Biotech (NASDAQ: MBRX) $33mn Mcap, ~$6mn cash

Pre-clinical and clinical stage pharma company developing anti-cancer drugs, some of which are based on discoveries of MD Anderson Cancer Center
Ongoing Phase II clinical trial for R/R AML. Two pre-clinical small molecule portfolios: 1) modulation of hard to target tumor cell signaling mechanisms and recruitment of patient’s own immune system and 2) targeting of tumor metabolism
For more information, visit www.moleculin.com

Nemus Bioscience (OTC: NMUS) $10mn Mcap

Bio-pharma company developing cannabinoid-based therapeutics, utilizing proprietary tech from U of MS, for specific indications, including ocular applications
For more information, visit www.nemusbioscience.com

Nephros (OTC: NEPH) $20mn Mcap

A commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis machine for the treatment of patients with end stage renal disease
For more information, visit www.nephros.com

Onconova Therapeutics (NASDAQ: ONTX) $21mn Mcap, ~$26mn cash

Phase 3 clinical-stage bio-pharma company with novel products to treat cancer
Most advanced product candidate, rigosertib, is a small molecular inhibitor of cellular signaling/RAS mimetic – awarded orphan designation for myelodysplastic syndrome
For more information, visit www.onconova.com

PixarBio Corporation (OTC: PXRB) $440mn Mcap, ~$7mn cash

Spec pharma/biotech company focused on novel neurological drug delivery systems for post-operative pain, epilepsy, Parkinson’s Disease, spinal cord injury
Lead product reports sustained therapeutic release of non-opiate drugs for post-operative, acute and chronic pain in pre-clinical studies
For more information, visit www.pixarbio.com

Xenetic Biosciences (OTC: XBIO) $28mn Mcap, ~$9mn cash

Clinical stage bio-pharma company focused on next-gen biologics and novel oncology therapeutics
Lead product candidates include polysialylated form of erythropoietin for anemia in pre-dialysis patients, orphan designated oncology therapeutics, and progesterone receptor negative endometrial cancer, as well as refractory AML. In partnership with Shire for novel series of polysialylated blood coagulant factors
For more information, visit www.xeneticbio.com

To Schedule a 1x1 Management Meeting, Contact:
PCG Advisory Group
Kirin Smith [e-mail] - 646-863-6519
Adam Holdsworth [e-mail] - 646-862-4602"

[Popeye82]

https://vts.inxpo.com/scripts/Server.nxp?LASCmd=L:0&AI=1&Ini…

[Popeye82]

40 cutting edge companies, @the Growth +Innovation Forum
www.sharesmagazine.co.uk/events/event/GIF2017?utm_source=mas…

[Popeye82]

Eine im Bestand,
ein bisschen von WL:


https://ceo17.eventsbio.com/connect/search.ww

"22nd Century 22nd Century Group, Inc., a plant biotechnology company, provides technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be... View More 30 minutes Company Presentation
Session Schedule
4SC AG 4SC is a biotech company dedicated to the research and development of small-molecule drugs focused on epigenetic mechanisms of action for the treatment of cancers with high... View More 30 minutes Company Presentation
Jason Loveridge
Session Schedule
AcelRx Pharmaceuticals AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of... View More 30 minutes Company Presentation
Timothy Morris
Session Schedule
Actinium Pharmaceuticals, Inc Actinium Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative targeted therapies for patients with cancers lacking effective treatment options.... View More 30 minutes Company Presentation
Session Schedule
AETERNA ZENTARIS Aeterna Zentaris is a specialty biopharmaceutical company focused on developing and commercializing therapies which enhance and improve the lives of patients worldwide. The... View More 30 minutes Company Presentation
David Dodd
Session Schedule
Agile Therapeutics, Inc Agile Therapeutics is a women’s health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products. Our... View More 30 minutes Company Presentation
Al Altomari
Session Schedule
Akari Therapeutics Plc Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of life-transforming treatments for a range of rare and orphan autoimmune... View More 30 minutes Company Presentation
Session Schedule
Akebia Therapeutics, Inc. Akebia Therapeutics, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on delivering innovative therapies to patients with kidney disease... View More 30 minutes Company Presentation
John Butler
Session Schedule
Albireo Pharma Inc Albireo Pharma, Inc. (NASDAQ:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators. Albireo’s clinical pipeline includes two... View More 30 minutes Company Presentation
Ron Cooper
Session Schedule
Alcobra Alcobra is merging pharmaceutical company (NASDAQ: ADHD) primarily focused on the development and commercialization of our proprietary drug, METADOXINE EXTENDED RELEASE... View More 30 minutes Company Presentation
Session Schedule
Altimmune, Inc. Altimmune is a clinical stage immunotherapeutic company focused on the development of products to stimulate robust and durable immune responses for the prevention and... View More 30 minutes Company Presentation
Bill Enright
Session Schedule
Anavex Life Sciences Corp. Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of differentiated therapeutics for the treatment of... View More 30 minutes Company Presentation
Christopher U. Missling, PhD
Session Schedule
Angionetics Inc. Angionetics is a biotechnology company focused on the clinical and commercial development of angiogenic, gene- based bio-therapeutics for the treatment of the almost 1.8... View More 30 minutes Company Presentation
Christopher Reinhard
Session Schedule
Apexian Pharmaceuticals Apexian Pharmaceuticals is a clinical-stage biotechnology company focused on developing novel compounds to treat cancer, targeting the multiple functions of the APE1... View More 30 minutes Company Presentation
Steve Carchedi
Session Schedule
Aquinox Pharmceuticals, Inc. We are a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Our primary focus is... View More 30 minutes Company Presentation
David Main
Session Schedule
Aradigm Corporation Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs for the prevention and treatment of severe respiratory... View More 30 minutes Company Presentation
Igor Gonda
Session Schedule
Arch Therapeutics, Inc. The Mission of Arch Therapeutics is to develop products that will improve the lives of patients and enhance the quality of care offered by healthcare personnel. We intend to... View More 30 minutes Company Presentation
Terrence Norchi
Session Schedule
Arena Pharmaceuticals, Inc. We are a biopharmaceutical company focused on developing novel, small molecule drugs across a range of therapeutic areas. We have three primary proprietary investigational... View More 30 minutes Company Presentation
Amit Munshi
Session Schedule
Argos Therapeutics, Inc Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious... View More 30 minutes Company Presentation
Jeff Abbey
Session Schedule
Atlantic Healthcare plc Atlantic Healthcare plc is an emerging trans-Atlantic pharmaceutical group addressing the clinical needs of patients under specialist care, with an existing focus on... View More 30 minutes Company Presentation
Toby Wilson Waterworth
Session Schedule
Aveo Oncology AVEO Oncology (AVEO) is a biopharmaceutical company dedicated to advancing a broad portfolio of targeted therapeutics for oncology and other areas of unmet medical need. The... View More 30 minutes Company Presentation
Michael Bailey
Session Schedule
Axsome Therapeutics, Inc. Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which... View More 30 minutes Company Presentation
Herriot Tabuteau
Session Schedule
Baebies, Inc. At Baebies our sole focus is to advance newborn screening and other pediatric testing worldwide. Baebies is guided by the vision that “everyone deserves a healthy start”.... View More 30 minutes Company Presentation
Session Schedule
Bellerophon Therapeutics We are focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary diseases. Our mission is to develop well-studied... View More 30 minutes Company Presentation
Fabian Tenenbaum
Session Schedule
BioLineRx Ltd. BioLineRx is a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates. The Company in-licenses novel... View More 30 minutes Company Presentation
Philip Serlin
Session Schedule
Bionomics Ltd Bionomics is a clinical stage biopharmaceutical company leveraging its proprietary technologies to discover and develop a deep pipeline of best in class, novel drug... View More 30 minutes Company Presentation
Deborah Rathjen
Session Schedule
Bio-Path Holdings, Inc. Bio-Path is a biotechnology company focused on developing therapeutic products utilizing DNAbilize™, its proprietary liposomal delivery and antisense technology, to... View More 30 minutes Company Presentation
Peter Nielsen
Session Schedule
BioTime, Inc. BioTime, Inc. is a clinical-stage biotechnology company focused on developing and commercializing products addressing degenerative diseases. The foundation of BioTime’s core... View More 30 minutes Company Presentation
Russell Skibsted
Session Schedule
Brainstorm cell Therapeutics BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases... View More 30 minutes Company Presentation
Session Schedule
Caladrius Biosciences, Inc. Caladrius Biosciences, Inc. is advancing a proprietary platform technology for immunomodulation by pioneering the use of T regulatory cells as an innovative therapy for... View More 30 minutes Company Presentation
David Mazzo
Session Schedule
Calithera Biosciences Calithera is discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. 30 minutes Company Presentation
Susan Molineaux
Session Schedule
Capnia, Inc. We develop novel products based on our proprietary technologies for precision metering of gas flow. Our first commercial product, the CoSense® ETCO Monitor, measures... View More 30 minutes Company Presentation
Anish Bhatnagar
Session Schedule
Cellectar Biosciences, Inc. Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers... View More 30 minutes Company Presentation
James Caruso
Session Schedule
Cellular Biomedicine Group Cellular Biomedicine Group is a clinical-stage biomedicine firm developing effective immunotherapies for cancer and stem cell therapies for degenerative diseases. CBMG's... View More 30 minutes Company Presentation
Tony Liu
Session Schedule
Centrexion Therapeutics, Corp. Centrexion Therapeutics, Corp. is focused on advancing the treatment of chronic moderate to severe pain with one of the largest exclusively pain-focused pipelines of... View More 30 minutes Company Presentation
Session Schedule
Chembio Diagnostics, Inc. Chembio Diagnostics, Inc. (NASDAQ: CEMI) develops, manufactures, licenses and markets rapid diagnostic assays in the growing $8.0 billion point-of-care (POC) testing market.... View More 30 minutes Company Presentation
John Sperzel
Session Schedule
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals (OTCQB: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing... View More 30 minutes Company Presentation
Session Schedule
Colby Pharmaceutical Company Colby Pharmaceutical Company is clinically developing small molecule anti-inflammatory and analgesic drugs as well as biologic immunotherapeutics. 30 minutes Company Presentation
Session Schedule
Conatus Pharmaceuticals Inc. We are a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. Our lead compound, emricasan, is a first-in-class,... View More 30 minutes Company Presentation
Steven Mento
Session Schedule
ConcentRx, Inc. ConcentRx is an IND-ready company with a patented cancer immunotherapy developed at Stanford University. We begin our process with a patient’s or a donor’s white cells.... View More 30 minutes Company Presentation
Pamela R. Contag, PhD
Session Schedule
ContraVir Pharmaceuticals, Inc. ContraVir is a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies with three candidates in the pipeline. Two of its... View More 30 minutes Company Presentation
James Sapirstein
Session Schedule
Corium International, Inc. Corium International, Inc. is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products... View More 30 minutes Company Presentation
Peter Staple
Session Schedule
CTI BioPharma Corp. CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of... View More 30 minutes Company Presentation
Richard Love
Session Schedule
Curetis N.V. Founded in 2007, Curetis is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for... View More 30 minutes Company Presentation
Oliver Schacht
Session Schedule
CV Sciences PHARMACEUTICALS CV Sciences’ Pharmaceutical Division is developing synthetically‐formulated cannabidiol‐based medicine, pursuing the approval of the U.S. Food and Drug... View More 30 minutes Company Presentation
Joseph Dowling
Session Schedule
Cyclacel Pharmaceuticals, Inc. Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company using cell cycle control and DNA damage response biology to develop innovative, targeted medicines for... View More 30 minutes Company Presentation
Spiro Rombotis
Session Schedule
Cymabay Therapeutics CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need,... View More 30 minutes Company Presentation
Sujal Shah
Harold Van Wart
Session Schedule
CytoSorbents CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based, critical care immunotherapy company specializing in blood purification to control deadly inflammation in... View More 30 minutes Company Presentation
Phillip Chan
Session Schedule
CytRx Corporation CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. CytRx recently announced positive Phase 3 results with its lead... View More 30 minutes Company Presentation
Steven Kriegsman
David Haen
Session Schedule
Dimerix Ltd Dimerix discovers and develops novel approaches based on G-protein coupled receptor (GPCR) heteromer modulation to improve human health. Dimerix's lead program is DMX-200,... View More 30 minutes Company Presentation

Editas Medicine Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes. The company... View More 30 minutes Company Presentation
Session Schedule
Eiger BioPharmaceuticals, Inc Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of Orphan diseases. Eiger has built a... View More 30 minutes Company Presentation
David Cory
Session Schedule
Eligo Bioscience Eligo Bioscience is an MIT-Rockefeller spinoff, cofounded by Prof Tim Lu and Dr. Xavier Duportet from MIT, and Prof Luciano Marriffini and Dr. David Bikard from Rockefeller... View More 30 minutes Company Presentation
Xavier Duportet
Session Schedule
EnBiotix, Inc EnBiotix is a product-focused bioengineering company commercializing anti-infective inventions of EnBiotix co-founder and SAB Chair Professor James J. Collins. Through... View More 30 minutes Company Presentation
Jeffrey Wager
Session Schedule
ENTEROME Enterome is pioneering the development of novel Pharmaceuticals and Diagnostics to support personalized therapies in microbiome-related diseases such as ... View More 30 minutes Company Presentation
Session Schedule
EpiBiome EpiBiome's mission is to surveil microbial populations and to develop the technologies that will protect humanity against the rising global threat of antibiotic resistance. 30 minutes Company Presentation
Nick Conley
Session Schedule
EryDel SpA EryDel SpA is a clinical stage biopharmaceutical company specialized in the development of drugs and diagnostics delivered through red blood cells by using a proprietary... View More 30 minutes Company Presentation
Luca Benatti
Session Schedule
Exactus, Inc. Exactus Inc. is a publicly traded life science company based in Richmond, Virginia that is developing and commercializing Point-of-Care (POC) diagnostics for measuring... View More 30 minutes Company Presentation
Session Schedule
Exicure Inc. Exicure is a clinical stage biotechnology company developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical... View More 30 minutes Company Presentation
David Giljohann
Session Schedule
Exosome Diagnostics, Inc. Exosome Diagnostics is focused on developing and commercializing revolutionary, biofluid-based diagnostics to deliver personalized precision healthcare that improves lives.... View More 30 minutes Company Presentation
Session Schedule
Foamix Pharmaceuticals Foamix is a specialty pharmaceutical company focused on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological... View More 30 minutes Company Presentation
Dov Tamarkin
Session Schedule
Fortress Biotech, Inc. Fortress Biotech, Inc. (“Fortress”) is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products.... View More 30 minutes Company Presentation
Session Schedule
Galectin Therapeutics Galectin Therapeutics is developing promising therapies for the treatment of fibrotic liver disease and cancer based on the Company's unique understanding of galectin... View More 30 minutes Company Presentation
Peter Traber
Session Schedule
Galena Biopharma, Inc. Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical... View More 30 minutes Company Presentation
Mark Schwartz
Session Schedule
GlaxoSmithKline, LLC Our mission is to help people do more, feel better, live longer. The business is focused around the delivery of three strategic priorities which aim to increase growth,... View More 30 minutes Company Presentation
William Mendez
Session Schedule
Gradalis, Inc. Gradalis is a fully integrated biotechnology company based in Dallas, Texas that focuses on the development, manufacturing, and commercialization of novel proprietary... View More 30 minutes Company Presentation
Sunil Joshi
Session Schedule
Gritstone Oncology, Inc Gritstone is a next-generation immuno-oncology company focused on developing personalized cancer vaccines to elicit a potent T cell response against neo-antigens expressed... View More 30 minutes Company Presentation
Session Schedule
Heat Biologics Heat Biologics, Inc. (Nasdaq:HTBX) is an immuno-oncology company developing novel therapies that are designed to activate a patient’s immune system against cancer utilizing... View More 30 minutes Company Presentation
Jeff Wolf
Session Schedule
HELIX BIOPHARMA CORP. Helix BioPharma Corporation is a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological... View More 30 minutes Company Presentation
Session Schedule
IMMUNICUM AB (publ) At Immunicum, we strive to develop sophisticated, safe and efficient therapeutic cancer treatments with powerful - and long lasting - immune responses. Immunicum AB (publ)... View More 30 minutes Company Presentation
CARLOS DE SOUSA
Session Schedule
ImmunoCellular Therapeutics Ltd About ImmunoCellular Therapeutics, Ltd. ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the... View More 30 minutes Company Presentation
Andrew Gengos
Session Schedule
Inotek Pharmaceuticals Corporation Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other eye... View More 30 minutes Company Presentation
David Southwell
Session Schedule
Invitae Corporation Invitae is a genetic information company whose mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of... View More 30 minutes Company Presentation
Sean George
Session Schedule
InVivo Therapeutics Corporation InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was... View More 30 minutes Company Presentation
Mark Perrin
Session Schedule
IonField Holdings LLC, dba IonField Systems IonField develops products and services allowing repeated reuse of labware in pharmaceutical and biotech research, and specialty diagnostic testing markets. The company’s... View More 30 minutes Company Presentation
Paul Hensley
Session Schedule
JN Medical Corp., With JNIMC’s proprietary technologies, we are developing not only the next generation of vaccines, but also vaccines for neglected or cure-known diseases. The strategic... View More 30 minutes Company Presentation
Session Schedule
KemPharm, Inc. KemPharm is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that are designed to be improved versions of... View More 30 minutes Company Presentation
TRAVIS MICKLE
Session Schedule
LexaGene Holdings Inc. To provide open-access instruments for rapid and cost-efficient pathogen detection that may be used in food-safety testing, animal diagnostics, and other applications. 30 minutes Company Presentation
Jack Regan
Session Schedule
MabVax Therapeutics Holdings, Inc. MabVax is a clinical stage immuno-oncology discovery and development company focused on harnessing the human immune system to create therapeutic and diagnostic products to... View More 30 minutes Company Presentation
Session Schedule
Madrigal Pharmaceuticals, Inc. Madrigal Pharmaceuticals, Inc. (Nasdaq: MGDL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor... View More 30 minutes Company Presentation
Paul Friedman
Session Schedule
Mast Therapeutics, Inc. Mast Therapeutics, Inc. is a publicly traded biopharmaceutical company headquartered in San Diego, California. The Company has two clinical-stage investigational new drugs,... View More 30 minutes Company Presentation
Brian Culley
Session Schedule
Mateon Therapeutics ------- 30 minutes Company Presentation
William Schwieterman
Session Schedule
MaxCyte, Inc. MaxCyte is an established and revenue generating US-based developer and supplier of cell engineering products and services to biopharmaceutical firms engaged in cell therapy,... View More 30 minutes Company Presentation
Douglas Doerfler
Session Schedule
Medovex Corporation Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products... View More 30 minutes Company Presentation
Session Schedule
MetaStat, Inc. MetaStat, Inc. (MTST) is a development stage biotechnology company focused on developing and commercialization of diagnostic tests that are prognostic for the risk of cancer... View More 30 minutes Company Presentation
Doug Hamilton
Session Schedule
Microbion Corporation Microbion Corporation is a pharmaceutical company in advanced human studies that is dedicated to overcoming biofilm-related, antibiotic-resistant infections with innovative,... View More 30 minutes Company Presentation
Karim Lalji
Session Schedule
Mount Tam Biotechnologies Mount Tam Biotechnologies was established in 2014 to develop, optimize and bring to market its portfolio of novel compounds across a range of disease states where mTORC1... View More 30 minutes Company Presentation
Richard Marshal
Session Schedule
NanoValent Pharmaceuticals Inc. NanoValent Pharmaceuticals, Inc. (NVP) is an early stage nanotechnology platform company, working closely with Childrens Hospital of LA, initially focused on oncology. Its... View More 30 minutes Company Presentation
Session Schedule
NeuroRx, Inc. NeuroRx is a small molecule biopharma company developing NRX-101 for the treatment of Acute Suicidal Ideation and Behavior, initially targeted at patients with bipolar... View More 30 minutes Company Presentation
Jonathan Javitt
Session Schedule
Noveome Biotherapeutics Noveome is a privately-held, clinical stage biotherapeutics company leveraging the science of paracrine signaling to develop safe and effective products that treat complex... View More 30 minutes Company Presentation
Clarke Atwell
Session Schedule
Novocure Limited Novocure (NASDAQ: NVCR) is a commercial-stage oncology company developing a novel, proprietary therapy called Tumor Treating Fields, or TTFields, for the treatment of solid... View More 30 minutes Company Presentation
William Doyle
Session Schedule
Ocugen, Inc. Ocugen is a clinical stage biopharmaceutical company developing novel treatments for sight threatening diseases including ocular graft versus host disease (oGVHD), retinitis... View More 30 minutes Company Presentation
Shankar Musunuri
Session Schedule
OncoMed Pharmaceuticals, Inc. OncoMed Pharmaceuticals is a clinical-stage biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic... View More 30 minutes Company Presentation
Paul Hastings
Session Schedule
Onconova Therapeutics, Inc. Onconova Therapeutics is a Phase 3 clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer. Onconova's clinical and... View More 30 minutes Company Presentation
Session Schedule
OncoSec Medical Incorporated Established in 2011, OncoSec Medical Incorporated is a San Diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and... View More 30 minutes Company Presentation
Punit Dhillon
Session Schedule
Opsona Therapeutics Ltd. Opsona Therapeutics is a leading immunology drug development company, focused on novel therapeutic approaches to key targets of the innate immune system associated with a... View More 30 minutes Company Presentation
Session Schedule
Oramed Pharmaceuticals Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed’s... View More 30 minutes Company Presentation
Session Schedule
Orexigen Therapeutics, Inc. Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Orexigen's first product, Contrave® (naltrexone HCl and bupropion HCl extended... View More 30 minutes Company Presentation
Mike Narachi
Session Schedule
ORYZON Oryzon is a Clinical Stage Biopharmaceutical company and one of the global leaders in the EPIGENETICS pharmaceutical space. We have developed internally a competitive... View More 30 minutes Company Presentation
Carlos Buesa
Session Schedule
OSE IMMUNOTHERAPEUTICS OSE Immunotherapeutics is a Euronext listed biotechnology company led by world-class immunologists and focused on the development of innovative immunotherapies for immune... View More 30 minutes Company Presentation
Dominique Costantini
Session Schedule

PAION AG PAION AG is a publicly listed specialty pharmaceutical company headquartered in Aachen (Germany) with further sites in Cambridge (United Kingdom) and New Jersey (USA).... View More 30 minutes Company Presentation
Wolfgang Soehngen
Session Schedule
Palatin Technologies, Inc. Palatin Technologies, Inc. (NYSE MKT: PTN) is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with... View More 30 minutes Company Presentation
Session Schedule
PhaseRx, Inc. PhaseRx is a leading biopharmaceutical company dedicated to developing products for the treatment of children with inherited enzyme deficiencies in the liver using... View More 30 minutes Company Presentation
Robert Overell
Session Schedule
Pieris Pharmaceuticals Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company applying its proprietary Anticalin® technology to create differentiated drugs that may help patients... View More 30 minutes Company Presentation
Session Schedule
Probiodrug AG Probiodrug AG (Euronext Amsterdam: PBD), is a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD) with a new therapeutic... View More 30 minutes Company Presentation
Konrad Glund
Session Schedule
Progenics Pharmaceuticals,Inc. Progenics Pharmaceuticals, Inc. is developing innovative medicines and other products for targeting and treating cancer, with a pipeline that includes several product... View More 30 minutes Company Presentation
Mark Baker
Session Schedule
ProLung ProLung’s mission is to make a difference in time for lung cancer patients who face an under-prioritized and highly stigmatized disease. Lung cancer is the leading cause of... View More 30 minutes Company Presentation
Steve Eror
Session Schedule
ProMetic Life Sciences ProMetic Life Sciences Inc. (www.prometic.com) is a long established biopharmaceutical company with globally recognized expertise in bioseparations, plasma-derived... View More 30 minutes Company Presentation
Pierre Laurin
Session Schedule
ProNAi Therapeutics ProNAi Therapeutics is a clinical stage drug development company advancing targeted therapeutics for the treatment of patients with cancer. We are an ambitious oncology... View More 30 minutes Company Presentation
Dr. Angie You
Session Schedule
Proove Biosciences Inc. Proove Biosciences is a commercial and research leader in personalized medicine. Proove has a portfolio of patent-protected genetic tests that help physicians answer some of... View More 30 minutes Company Presentation
Brian Meshkin
Session Schedule
Proteon Therapeutics, Inc. Proteon Therapeutics is a late-stage biopharmaceutical company committed to improving the lives of patients and families affected by kidney and vascular diseases. We are... View More 30 minutes Company Presentation
Timothy Noyes
Session Schedule
RaNA Therapeutics RaNA Therapeutics is a leading biotechnology company committed to the development of next generation RNA-targeted medicines that selectively upregulate gene expression to... View More 30 minutes Company Presentation
Ronald Renaud
Session Schedule
Realm Therapeutics, Inc. PuriCore (AIM:PURI) is a biopharmaceutical company passionately committed to leveraging its proprietary immunomodulatory technology to protect and improve the health of... View More 30 minutes Company Presentation
Alex Martin
Session Schedule
Rebiotix, Inc. Rebiotix is the most clinically advanced microbiome therapeutics company in the industry. Its Phase 3-ready drug candidate, RBX2660, is the first candidate to complete a... View More 30 minutes Company Presentation
Lee Jones
Session Schedule
RedHill Biopharma Ltd. RedHill Biopharma Ltd. is a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small... View More 30 minutes Company Presentation
Dror Ben-Asher
Session Schedule
Relmada Therapeutics, Inc. Relmada Therapeutics is a clinical-stage, publicly traded biotechnology company developing novel versions of proven drug products together with new chemical entities that... View More 30 minutes Company Presentation
Session Schedule
RespireRx Pharmaceuticals Inc. RespireRx Pharmaceuticals Inc. (OTC QB: RSPI) is a leader in the discovery and clinical and regulatory development of innovative pharmaceuticals for the treatment of... View More 30 minutes Company Presentation
Session Schedule
Resverlogix Corp. Resverlogix is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra-terminal) inhibitor. BET bromodomain... View More 30 minutes Company Presentation
Donald McCaffrey
Session Schedule
Rocket Pharmaceuticals, Ltd Rocket Pharmaceuticals, Ltd is a biotechnology company focused on seeking cures through molecular and gene therapy. We are developing first-in-class treatments for patients... View More 30 minutes Company Presentation
Gaurav Shah
Session Schedule
Rosetta Genomics Rosetta Genomics develops and commercializes a full range of microRNA-based and other molecular diagnostics. Rosetta’s integrative research platform combining bioinformatics... View More 30 minutes Company Presentation
Kenneth Berlin
Ron Kalfus
Session Schedule
RXi Pharmaceuticals Corporation RXi Pharmaceuticals Corporation is a clinical-stage RNAi company developing innovative therapeutics that address significant high-unmet medical needs. Building on the... View More 30 minutes Company Presentation
Geert Cauwenbergh
Session Schedule
Salarius Pharmaceuticals Formed in 2011, Salarius Pharmaceuticals is developing targeted therapies to treat pediatric and other cancers, including prostate cancer. Our lead compound, SP-2577, is a... View More 30 minutes Company Presentation
David Arthur
Session Schedule
SciClone Pharmaceuticals Inc SciClone Pharmaceuticals is a revenue-generating, specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major... View More 30 minutes Company Presentation
Friedhelm Blobel
Session Schedule
sdfdsf sdfsdf 30 minutes Company Presentation
Session Schedule
Serina Therapeutics, Inc. Serina Therapeutics is a privately held pharmaceutical company located at the Hudson-Alpha Institute for Biotechnology in Huntsville, AL. We have developed novel polymer... View More 30 minutes Company Presentation
Session Schedule
Sorrento Therapeutics Sorrento is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for immuno-oncology, inflammation and autoimmune diseases. Sorrento's lead... View More 30 minutes Company Presentation
Session Schedule
Spotlight Innovation Inc. Spotlight Innovation Inc. (OTCQB: STLT) identifies and acquires rights to innovative, proprietary technologies designed to address unmet medical needs, with an emphasis on... View More 30 minutes Company Presentation
Geoffrey M. Laff Ph.D.
Session Schedule
Spring Bank Pharmaceuticals, Inc. Spring Bank Pharmaceuticals (NASDAQ:SBPH) is a clinical stage biopharmaceutical company focused on the development of small molecule nucleic acid hybrids (SMNHs) with... View More 30 minutes Company Presentation
Session Schedule
Summit Therapeutics Summit is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only... View More 30 minutes Company Presentation
Erik Ostrowski
Session Schedule
Sunesis Pharmaceuticals Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the potential treatment of solid and hematologic... View More 30 minutes Company Presentation
Dan Swisher
Session Schedule
Sutro Biopharma Inc. Sutro Biopharma, located in South San Francisco, is developing a new generation of multi-functional antibody drug conjugate combination therapeutics and bifunctional... View More 30 minutes Company Presentation
William Newell
Session Schedule
Symic Bio, Inc. Symic Bio is a private, clinical-stage biopharma company. Symic has a new therapeutic category of bioconjugates that are focused on extracellular matrix biology. These drugs... View More 30 minutes Company Presentation
Ken Horne
Session Schedule
Synthetic Biologics, Inc Synthetic Biologics, Inc. (NYSE MKT: SYN) is a late-stage clinical company developing therapeutics focused on the gut microbiome. The Company's lead candidates poised for... View More 30 minutes Company Presentation
Jeff Riley
Session Schedule
Tarveda Therapeutics Tarveda Therapeutics, Inc., discovers and develops Pentarins™, a new class of potent and selective miniaturized drug conjugates with high-targeting capabilities for the... View More 30 minutes Company Presentation
Andrew Fromkin
Session Schedule
testing JR 09292016 testing JR 09292016 30 minutes Company Presentation
Session Schedule
ThromboGenics nv ThromboGenics is a biopharmaceutical company focused on developing innovative treatments for diabetic eye disease. The company’s attractive pipeline of disease modifying... View More 30 minutes Company Presentation
Session Schedule
TiGenix NV TiGenix NV (Euronext Brussels: TIG) is an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of... View More 30 minutes Company Presentation
Session Schedule
TxCell SA TxCell is a biotechnology company that develops platforms for innovative, personalized T cell immunotherapies for the treatment of severe chronic inflammatory and autoimmune... View More 30 minutes Company Presentation
Stéphane Boissel
Session Schedule
Universal Stabilization Technologies, Inc. Universal Stabilization Technologies, Inc. ("UST") is a San Diego-based biotechnology company with a platform for the development of thermostable live attenuated vaccines... View More 30 minutes Company Presentation
Session Schedule
Valin Technologies Ltd Valin Technologies Ltd. is focused on the development of innovative biologics and biosimilars. Valin's management expertise encompasses the entire biologic product life... View More 30 minutes Company Presentation
Session Schedule
Vascular Biogenics LTD Vascular Biogenics Ltd., operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of... View More 30 minutes Company Presentation
Session Schedule
Vaxess Technologies Vaxess was founded in 2012 to enable the next generation of vaccines. The company has combined VC funding with pharmaceutical partnerships to advance two platforms. Matrix is... View More 30 minutes Company Presentation
Michael Schrader
Session Schedule
Vaxil Bio Ltd. Novel Immuno-Oncology Pathways Pioneering New Cancer Antigens & Antibodies Vaxil is a clinical stage immuno-oncology biotech with R&D based in the Weizmann Science Park,... View More 30 minutes Company Presentation
Limor Chen
Session Schedule
Verastem, Inc. Verastem, Inc. (NASDAQ:VSTM) is a biopharmaceutical company focused on discovering and developing drugs to improve outcomes for patients with cancer. Verastem is currently... View More 30 minutes Company Presentation
Daniel Paterson
Session Schedule
Vical Incorporated Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies... View More 30 minutes Company Presentation
Session Schedule
Viking Therapeutics, Inc. Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and... View More 30 minutes Company Presentation
Brian Lian
Session Schedule
WILEX AG WILEX AG is a biopharmaceutical company based in Munich, Germany, that serves as a parent and holding company. The Company’s research and development work is conducted by its... View More 30 minutes Company Presentation
Jan Schmidt-Brand
Session Schedule
Zenith Epigenetics Ltd. Zenith Epigenetics is a clinical stage biotechnology company with a broad and deep drug discovery platform in epigenetics, developing orally active, small molecules that are... View More 30 minutes Company Presentation
Donald McCaffrey"

[Popeye82]

Keine im Bestand, 4 (erweiterte)Watchliste:

NobleCON13
http://conferences.networknewswire.net/2017/noble/index.php

"Engility Holdings (EGL)

Engility Holdings (NYSE: EGL) provides integrated solutions and services for the U.S. government, supporting customers throughout defense, intelligence, space, federal civilian and international communities. The company offers various engineering, technical, analytical, advisory, training, logistics and support services worldwide, as well as services in the areas of specialized technical consulting, program and business support, engineering and technology life-cycle support, information technology modernization and sustainment, supply chain and logistics management, and training and education. For more information, visit the company's website at www.engilitycorp.com.
IEC Electronics (IEC)

IEC Electronics (NYSE: IEC) provides electronic contract manufacturing services in the United States. It specializes in delivering technical solutions for the custom manufacturing, product configuration and verification testing of complex products that require a sophisticated level of manufacturing. The company manufactures a range of assemblies that are incorporated into various products, such as aerospace and defense systems, medical devices, industrial equipment, and transportation products. It serves aerospace, medical, industrial and defense sectors through a direct sales force, as well as through a network of manufacturer's representatives. For more information, visit the company's website at www.iec-electronics.com.
Panhandle Oil & Gas (PHX)

Panhandle Oil & Gas (NYSE: PHX) acquires, develops and manages oil and natural gas properties in the United States. The company produces and sells natural gas, crude oil, and natural gas liquids. Its mineral and leasehold properties are located in Arkansas, New Mexico, North Dakota, Oklahoma and Texas. As of September 30, 2016, the company owned 255,019 net mineral acres; leased 19,532 net acres; and held working and royalty interests in 6,233 producing oil and natural gas wells, as well as 45 wells in the process of being drilled or completed. For more information, visit the company's website at www.panhandleoilandgas.com.
U.S. Auto Parts Network (PRTS)

U.S. Auto Parts Network (NASDAQ: PRTS) is an online retailer of aftermarket auto parts and accessories primarily in the United States, Canada and the Philippines. The company operates through two segments - Base USAP and AutoMD – through which it offers body parts, such as parts for the exterior of an automobile; mirror products; engine parts comprising engine and chassis components, as well as other mechanical and electrical parts; and performance parts and accessories to individual consumers through its network of websites and online marketplaces. The company also sells and delivers auto parts to collision repair shops from its Chesapeake, Virginia, warehouse facility; markets Kool-Vue products to auto parts wholesale distributors; and serves consumers by operating a retail outlet store in LaSalle, Illinois. For more information, visit the company's website www.usautoparts.net.
10:00 am
Avino Silver & Gold Mines (ASM)

Avino Silver & Gold Mines (NYSE: ASM) is engaged in the production and sale of silver, gold and copper bulk concentrates, as well as in the exploration, evaluation and acquisition of mineral properties. The company owns 42 mineral claims and leases four mineral claims in the state of Durango, Mexico. It also holds 100% interests in the Bralorne mine located in the Lillooet mining division, British Columbia, Canada; and the Eagle property located in the Mayo mining division of Yukon, Canada. Avino Silver & Gold Mines Ltd. was founded in 1968 and is headquartered in Vancouver, Canada. For more information, visit the company's website at www.avino.com.
Orbit International (ORBT)

Orbit International (OTC: ORBT) designs, manufactures and sells electronic components and subsystems, as well as commercial and custom power units for prime contractors, government procurement agencies, and research and development laboratories primarily in the United States. The company operates in two segments: Electronics Group and Power Group. The Electronics Group segment engages in the design, manufacture and sale of customized electronic components and subsystems. The company also designs and manufactures below-deck control products for naval combat systems and gun weapon systems, and provides systems integration for gun weapons systems and fire control interface. For more information, visit the company's website at www.orbitintl.com.
PAR Technology (PAR)

PAR Technology (NYSE: PAR) primarily provides technology solutions to businesses and organizations in the global hospitality industry. The company operates in two segments: Hospitality and Government. The Hospitality segment offers hardware, software and a range of support services, including point-of-sale (POS) terminals, tablets, kitchen systems utilizing printers and/or video monitors, and various food safety monitoring and task management hardware and software solutions, as well as front-of-store POS software applications, operations management software applications, and enterprise software applications for content management and business intelligence. The company's Government Business segment provides computer-based system design, engineering and technical services to the Department of Defense and various federal agencies. For more information, visit the company's website at www.partech.com.
10:30 am
Akoustis Technologies (AKTS)

Akoustis Technologies (OTC: AKTS) operates in the telecommunications and fiber optics sector where it designs and manufactures various radio frequency (RF) filters enabling the RF front-end of mobile wireless devices, such as smartphones and tablets. Akoustis focuses on manufacturing and commercializing its patent-pending Bulk ONE acoustic wave technology to address the frequency-selectivity requirements in mobile smartphones, enhancing the efficiency and signal quality of mobile wireless devices and enabling The Internet of Things. For more information, visit the company's website at www.akoustis.com.
Fusion Telecommunications International (FSNN)

Fusion Telecommunications International (NASDAQ: FSNN) provides cloud communications, cloud connectivity, cloud infrastructure, cloud computing, and managed cloud-based solutions to small, medium and large businesses worldwide. The company also offers voice services to communications carriers. Fusion's Business Services segment offers cloud voice and unified communications, which enhance communication and collaboration on virtually any device and anywhere; cloud connectivity services that connect customers to the cloud with managed network solutions; and cloud computing and infrastructure as service solutions that are designed to provide enterprise customers with a platform on which additional cloud services can be built. For more information, visit the company' website at www.fusionconnect.com.
Tronc (TRNC)

Tronc (NASDAQ: TRNC) is a multiplatform media and marketing solutions company that operates 11 daily newspapers; 160 weekly or monthly community/niche publications and products; approximately 120 digital platforms online and on mobile; and provides a suite of digital marketing services for local, regional, and national marketers. The company was formerly known as Tribune Publishing Company and changed its name to Tronc, Inc. in June 2016. For more information, visit the company's website www.tronc.com.
VolitionRx (VNRX)

VolitionRx (NYSE: VNRX) is a clinical-stage life sciences company focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The company is involved in the development of 28 epigenetic NuQ blood assays based on its Nucleosomics biomarker discovery platform. VolitionRx develops two blood assays in the NuQ-X family to detect the presence of cancer by detecting nucleosomes containing specific nucleotides; and three blood tests in the NuQ-V family to detect cancer by detecting nucleosomes containing specific histone variants. The company also develops 17 blood assays in the NuQ-M family to detect cancer by detecting nucleosomes containing modified histones that are proteins for packaging and ordering DNA into nucleosomes; five blood assays in the NuQ-A family to detect cancer by detecting nucleosome-protein adducts; and a NuQ-T assay to detect cancer by detecting total blood nucleosome levels. For more information, visit the company's website www.volitionrx.com.
11:00 am
CPI Aerostructures (CVU)

CPI Aerostructures (NYSE: CVU) engages in the contract production of structural aircraft parts for fixed wing aircraft and helicopters in the commercial and defense aerospace markets. It offers aircraft structural parts, such as skin panels, leading edges, flight control surfaces, engine components, wing tips, cowl doors, nacelle assemblies, and inlet assemblies for military aircraft; and reconnaissance pod structures and fuel panel systems. The company also operates as a subcontractor for defense prime contractors and commercial contractors, as well as the United States Department of Defense, primarily the Air Force. For more information, visit the company's website at www.cpiaero.com.
MaxPoint Interactive (MXPT)

MaxPoint Interactive (NASDAQ: MXPT) operates as a marketing technology company in the United States and Europe. The company offers business intelligence and marketing automation software service that enables national brands to drive local in-store sales. It sells its solution directly to enterprises in consumer products, retail, automotive, financial services, healthcare, telecommunications and entertainment industries, as well as advertising agencies. MaxPoint Interactive, Inc. was founded in 2006 and is headquartered in Morrisville, North Carolina. For more information, visit the company's website at www.maxpoint.com.
Nuvo Pharmaceuticals (NRIFF)

Nuvo Pharmaceuticals (OTC: NRIFF) is a life sciences company operating through two segments, Nuvo Pharma and Crescita. It offers Pennsaid, a topical non-steroidal anti-inflammatory drug that is used to treat the signs and symptoms of osteoarthritis of the knee; Pennsaid 2%, a follow-on product to Pennsaid for the treatment of the pain of knee osteoarthritis; and heated lidocaine/tetracaine (HLT) patch. The company also provides Pliaglis, a topical local anesthetic cream that provides local dermal anesthesia on intact skin prior to superficial dermatological procedures. For more information, visit the company's website at www.nuvopharmaceuticals.com.
11:30 am
Diversified Restaurant Holdings (SAUC)

Diversified Restaurant Holdings (NASDAQ: SAUC) operates as a restaurant company in the United States. The company operates Buffalo Wild Wings Grill & Bar franchised restaurants, which primarily offer chicken wings, boneless wings, and other items, including chicken tenders, flatbreads, popcorn shrimps, specialty hamburgers and sandwiches, wraps, soft tacos, appetizers and salads. As of June 21, 2016, Diversified Restaurant Holdings operated 64 Buffalo Wild Wings Grill & Bar franchised restaurants in Florida, Illinois, Indiana, Michigan and Missouri. For more information, visit the company's website at www.diversifiedrestaurantholdings.com.
SilverSun (SSNT)

SilverSun (OTCBB: SSNT) is a business application, technology and consulting company for small- and medium-sized businesses. The company resells enterprise resource planning financial accounting software that provides various functions related to accounting, including financial reporting, accounts payable and accounts receivable, and inventory management; and provides training, technical support, and professional services. The company also publishes and markets MAPADOC, an electronic data interchange software to small and medium-sized business customers through a network of resellers. In addition, it resells warehouse management system software, which controls the movement and storage of materials within an operation, and processes the associated transactions. For more information, visit the company's website www.silversuntech.com.
Townsquare Media (TSQ)

Townsquare Media (NYSE: TSQ) operates as a media, entertainment and digital marketing solutions company in small and mid-sized markets. The company's Local Advertising segment offers broadcast, digital and mobile advertising services through its radio stations, websites, radio stations, online streams and mobile applications. Its Live Events segment creates, promotes, and produces live events, including music concerts, music festivals, consumer expositions and trade shows, athletic events, and lifestyle events, as well as mobile amusement parks at fairs, and other forms of entertainment. This segment also offer event production services to third parties, and owns a proprietary ticketing platform. For more information, visit the company's website www.townsquaremedia.com.
Axcelis Technologies (ACLS)

Axcelis Technologies (NASDAQ: ACLS) designs, manufactures and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. It offers a line of high energy, high current and medium current implanters for all application requirements. The company also provides dry strip systems for smaller wafers. In addition, Axcelis offers extensive aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. The company sells its equipment and services to semiconductor chip manufacturers through direct sales force. For more information, visit the company's website at www.axcelis.com.
12:00 pm
Rand Capital (RAND)

Rand Capital (NASDAQ: RAND) is a business development company specializing in venture capital and private equity investments. The firm prefers to make investments through equity or debt instruments in early venture, expansion stage, and in small to medium-sized privately held companies. It generally lends to more mature companies. Focused on companies engaged in the exploitation of new or unique products, technologies, or services, Rand Capital invests in healthcare, consumer products, manufacturing, software, and professional services. It seeks to invest in companies based in the Western and Upstate New York region and its surrounding states with focus on Buffalo and Niagara region. The firm may invest in region within three to five hour drives from Western New York, including Canada. For more information, visit the company's website at www.rand.org.
12:30 pm
Lilis Energy (LLEX)

Lilis Energy (OTC: LLEX) acquires, drills for, and produces oil and natural gas properties and prospects in the United States. The company holds interests in approximately 5,300 net acres in Permian Basin and approximately 7,600 net acres in the Denver-Julesburg basin. As of December 31, 2015, it had estimated proved reserves of 33,430 barrels of oil, and 141,450 thousand cubic feet of natural gas. The company was formerly known as Recovery Energy, Inc. and changed its name to Lilis Energy, Inc. in December 2013. For more information, visit the company's website at www.lilisenergy.com.
Tapinator (TAPM)

Tapinator (OTC: TAPM) develops and publishes mobile games on the iOS, Google Play, and Amazon platforms. The company's portfolio includes over 250 mobile gaming titles that have collectively achieved over 300 million player downloads, primarily within the Simulation, Arcade, Role Playing, Casino and Sports genres. A number of these titles have risen to the top of the mobile leaderboard charts and have been featured by the Apple, Google, and Amazon App Stores including games such as Rocky, Combo Quest and Burn It Down. The company generates revenues through the sale of branded advertisements, paid downloadable games and premium in-game content. For more information, visit the company's website www.tapinator.com.
VBI Vaccines (VBIV)

VBI Vaccines (NASDAQ: VBIV) is a commercial-stage biopharmaceutical company that develops vaccine candidates and novel technology platforms in Israel and internationally. The company's products are based on eVLP, a platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccines platform, a proprietary formulation and process that allow vaccines and biologics to preserve stability, potency, and safety. The company's commercial stage product is Sci-B-Vac, a third-generation licensed hepatitis B vaccine for adults, children, and newborn infants. It is also involved in CMV vaccine program, which is in phase I clinical trials for the prevention of cytomegalovirus infection; GBM immunotherapy program, a preclinical stage glioblastoma multiforme therapeutic vaccine candidate; and RSV vaccine program, a discovery stage novel respiratory syncytial virus vaccine candidate. For more information, visit the company's website www.vbivaccines.com.
1:00 pm
Applied DNA Sciences (APDN)

Applied DNA Sciences (NASDAQ: APDN) provides biotechnology-based security solutions for supply chain security, brand protection, and law enforcement applications in the United States, Europe and Asia. The company's principal supply chain security and product authentication solutions include SigNature DNA markers that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track and convict criminals; SigNature T DNA markers, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber, which determines whether the intended cotton DNA is present in fiber, yarn, or fabric. For more information, visit the company's website at www.adnas.com.
Capstone Companies (CAPC)

Capstone Companies (OTC: CAPC) designs, manufactures and sells power failure lighting solutions and other consumer products in North America and internationally. Its consumer lighting products include power failure multi-function handheld and night lights, wall-plates, decorative nightlights, wireless motion sensor lights, remote control battery powered accent lights, and remote control outlets. The company markets and sells its products under the CAPI and Capstone Lighting brand names through independent sales force, distributors and wholesalers who focus on mass merchandisers, warehouse clubs, department stores, and hardware centers, as well as food, drug and convenience stores. For more information, visit the company's website at www.capstonecompaniesinc.com.
Matinas BioPharma Holdings (MTNB)

Matinas BioPharma Holdings (OTC: MTNB) is a clinical-stage biopharmaceutical company, focuses on identifying and developing therapeutics for the treatment of fungal and bacterial infections. The company develops orally delivered therapeutics based on a proprietary, lipid crystal drug delivery platform called cochleate delivery technology. Its lead product candidate is MAT 2203, an oral formulation of the broad spectrum anti-fungal drug amphotericin B that is in Phase II study for the treatment of fungal infections. For more information, visit the company's website at www.matinasbiopharma.com.
The Geo Group (GEO)

The Geo Group (NYSE: GEO) provides government-outsourced services specializing in the management of correctional, detention and re-entry facilities, as well as the provision of community based services and youth services in the United States, Australia, South Africa, the United Kingdom, and Canada. The Geo Group operates through four segments: U.S. Corrections & Detention, GEO Community Services, International Services, and Facility Construction & Design. The company owns, leases and operates a range of correctional and detention facilities, including maximum, medium, and minimum security prisons; immigration detention centers; minimum security detention centers; and community based re-entry facilities. The company also provides monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers and pretrial defendants; as well as services to immigration and customs enforcement for the provision of services to improve the participation of non-detained aliens in the immigration court system. For more information, visit the company's website geogroup.com.
1:30 pm
Endeavour Silver (EXK)

Endeavour Silver (NYSE: EXK) is a mid-tier precious metals mining company engaged in the acquisition, exploration, development, extraction, processing, refining and reclamation of mining properties in Mexico and Chile. The company primarily explores for silver and gold deposits, and holds interest in the Guanaceví mine in the Durango state, and the Bolañitos and El Cubo mines in the Guanajuato state of Mexico. It also owns interests in various exploration properties, including the Guadalupe y Calvo and Parral projects in Chihuahua, Mexico; the Terronera project in Jalisco, Mexico; and the Lourdes locate in Guanajuato state of Mexico. For more information, visit the company's website at www.edrsilver.com.
Five Prime Therapeutics (FPRX)

Five Prime Therapeutics (NASDAQ: FPRX) is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company's product candidates include FPA008 in phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; phase I/II clinical trials for the treatment of pigmented villonodular synovitis tumor; and phase I clinical trials for the treatment of rheumatoid arthritis. Its product candidates also comprise FPA144, an antibody that inhibits fibroblast growth factor receptor IIb and is in phase I clinical trials to treat patients with gastric cancer; and FP-1039/GSK3052230, a fusion protein that traps and neutralizes cancer-promoting fibroblast growth factors. For more information, visit the company's website at www.fiveprime.com.
ITUS (ITUS)

ITUS (NASDAQ: ITUS) funds, develops, acquires and licenses emerging technologies in the areas of biotechnology. The company, through its subsidiary, Anixa Diagnostics Corporation, is developing a platform called Cchek, a series of non-invasive, blood tests for the early detection of solid tumor based cancers. It has a collaborative research agreement with The Wistar Institute for the development and validation of Cchek. The company was formerly known as CopyTele, Inc. and changed its name to ITUS Corporation in September 2014. For more information, visit the company's website at www.ituscorp.com.
MYnd Analytics (MYAN)

MYnd Analytics (OTC: MYAN) operates as a predictive analytics company. The company offers objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder, and other non-psychotic disorders. The company uses its proprietary neurometric platform, PEER Online, to generate Psychiatric electroencephalogram (EEG) Evaluation Registry (PEER) reports to predict the likelihood of response by an individual to a range of medications prescribed for the treatment of behavioral disorders. For more information, visit the company's website at www.myndanalytics.com.
2:00 pm
Eyegate Pharmaceuticals (EYEG)

Eyegate Pharmaceuticals (NASDAQ: EYEG) is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye. EGP-437, the company's first product in clinical trials, incorporates a reformulated topically active corticosteroid that is delivered into the ocular tissues through EyeGate's proprietary innovative drug delivery system, the EyeGate® II Delivery System. In addition, the company is developing, through its wholly owned Jade subsidiary, products using cross-linked thiolated carboxymethyl hyaluronic acid ("CMHA-S"), a modified form of the natural polymer hyaluronic acid (HA), which possesses unique physical and chemical properties such as hydration and healing properties. For more information, visit the company's website at www.eyegatepharma.com.
Great Panther Silver (GPL)

Great Panther Silver (NYSE: GPL) is a primary silver mining and exploration company listed on the Toronto Stock Exchange trading under the symbol GPR, and on the NYSE MKT trading under the symbol GPL. Great Panther's current activities are focused on the mining of precious metals from its two wholly-owned operating mines in Mexico: the Guanajuato Mine Complex, which includes the San Ignacio Mine, and the Topia Mine in Durango. In addition, the company has recently signed an agreement to acquire a 100% interest in the Coricancha Mine Complex in the central Andes of Peru. For more information, visit the company's website at www.greatpanther.com.
Innodata (INOD)

Innodata (NASDAQ: INOD) provides technology solutions and services worldwide, operating through three segments: Content Services (CS), Innodata Advanced Data Solutions (IADS), and Media Intelligence Solutions (MIS). The CS segment produces and distributes e-books, develops new digital information products, and provides operational support services for existing digital information products and systems, including content aggregation, extraction, encoding, indexing and abstracting, fabrication, and distribution. The IADS segment offers services that enable clients in the financial services, insurance, medical and healthcare sectors to enhance decision-support through digital technologies. For more information, visit the company's website at www.innodata.com.
Salem Media (SALM)

Salem Media (NASDAQ: SALM) operates as a multi-media company in the United States. The company owns and operates radio networks, which produce and distribute talk, news and music programming to radio stations in the United States, as well as sells commercial airtime to national advertisers and independent radio station affiliates. It also provides Christian and conservative-themed content, audio and video streaming, and other resources digitally through Christian content websites, such as OnePlace.com, Christianity.com, Crosswalk.com, GodVine.com, Jesus.org, and BibleStudyTools.com; and conservative opinion Websites, such as Townhall.com, HotAir.com, Twitchy.com, HumanEvents.com, and RedState.com. For more information, visit the company's website www.salem.cc.
2:30 pm
Anavex Life Sciences (AVXL)

Anavex Life Sciences (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company engaged in the development of drug candidates for the treatment of pain, Alzheimer's disease, other central nervous system diseases, and various cancers. The company's lead drug candidates include ANAVEX 2-73, a phase IIa clinical trial for the treatment of Alzheimer's disease; also in preclinical stage to treat Parkinson's disease. Its preclinical drug candidates include ANAVEX 3-71, which uses ligands that activate sigma-1 and M1 muscarinic receptors to treat Alzheimer's disease; ANAVEX 1-41, a sigma-1 agonist that protects nerve cells from degeneration or death; ANAVEX 1037 for the treatment of prostate cancer; and ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the treatment of neuropathic and visceral pain. For more information, visit the company's website at www.anavex.com.
Cellectar Biosciences (CLRB)

Cellectar Biosciences (NASDAQ: CLRB) is engaged in the development of targeted phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. It offers CLR 131, a PDC radiotherapeutic product candidate currently being evaluated in a phase I study for the treatment of relapse or refractory multiple myeloma; CLR 125, a cancer-targeting radiotherapeutic is under pre-clinical investigation for the treatment of micrometastatic disease ; CLR 124, a cancer-targeting positron emission tomography (PET) imaging PDC for the selective detection of tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting NIR-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. For more information, visit the company's website at www.cellectar.com.
OptimizeRx (OPRX)

OptimizeRx (OTC: OPRX) provides technology solutions for the health care industry. The company offers pharmaceutical manufacturers a direct-to-consumer and/or direct to physician channel for communicating and promoting the company's products. Its products include SampleMD, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through EMR or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies. For more information, visit the company's website at www.optimizerx.com.
RLJ Entertainment (RLJE)

RLJ Entertainment (NASDAQ: RLJE) is an entertainment content distribution company primarily in North America, the United Kingdom, and Australia. The company's titles are distributed in multiple formats including broadcast television (including satellite and cable), theatrical and non-theatrical, DVD, Blu-Ray, digital download, and digital streaming. It owns the OTT branded channels, Acorn TV (British TV) and UMC (Urban Movie Channel). The company targets distinct, premium audiences and urban niche audiences. It grows its proprietary digital channels through development, acquisition, and distribution of exclusive rights of program franchises and feature film content. Through Acorn Media Enterprises, its UK development arm, RLJE owns all rights to the hit UK mystery series Foyle's War and is developing new programs. For more information, visit the company's website at www.rljentertainment.com.
SeaChange (SEAC)

SeaChange (NASDAQ: SEAC) provides multiscreen video products and services that facilitate the aggregation, licensing, management and distribution of video and television advertising content to cable system operators, satellite operators, and telecommunications and media companies worldwide. The company offers multiscreen video products, including SeaChange Adrenalin, a multiscreen back office platform that enables service providers to manage, monetize and deliver a seamless viewing experience across televisions, personal computers (PCs), tablets, smart phones, and other IP-enabled devices; and SeaChange AssetFlow, which is used to receive, manage, and publish content for on-demand viewing on televisions, tablets, PCs and other consumer devices. For more information, visit the company's website www.schange.com.
3:00 pm
Energy Fuels (UUUU)

Energy Fuels (NYSE: UUUU) is engaged in the extraction, recovery and sale of uranium and vanadium properties in the United States. The company operates in two segments, ISR Uranium and Conventional Uranium. Its principal properties are located in Utah, Wyoming, Arizona, New Mexico and Colorado. The company owns the Nichols Ranch uranium recovery facility in Wyoming; White Mesa Mill in Utah; and uranium and uranium/vanadium properties and projects in various stages of exploration, permitting, and evaluation. Its White Mesa Mill also recovers vanadium as a co-product of mineralized material produced from certain of its projects in Colorado and Utah, as well as recovers uranium from other uranium-bearing materials. For more information, visit the company's website at www.energyfuels.com.
Social Reality (SRAX)

Social Reality (NASDAQ: SRAX) is an Internet advertising and platform technology company that provides tools to automate the digital advertising market in the United States, enabling publishers and advertisers to maximize their digital advertising initiatives. The company's Social Reality Ad Exchange (SRAX) is a real-time bidding sell side and buy side representation technology that assists publishers in delivering their media inventory to the real-time bidding exchanges; SRAX MD, an ad targeting and data platform for healthcare brands, agencies, and medical content publishers; SRAX Social, a social media and loyalty platform that allows brands to launch and manage their social media initiatives; and SRAX APP, a platform that allows publishers and content owners to launch native mobile applications through its SRAX platform. For more information, visit the company's website www.socialreality.com.
Uniroyal Global (UNIR)

Uniroyal Global (OTC: UNIR) develops, manufactures and distributes vinyl coated fabrics products that have applications in the automotive and non-automotive transportation, indoor/outdoor furniture, commercial and hospitality seating, healthcare facilities, athletic equipment, and residential primarily in North America and Europe. The company's products in the automotive industry are used primarily in seating, door panels, head and arm rests, security shades, and trim components. Its non-automotive applications include outdoor seating for utility and sports vehicles; and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pram and nursery, movie screen, and decorative surface applications. For more information, visit the company's website www.uniroyalglobal.com.
3:30 pm
Hyperdynamics (HDYN)

Hyperdynamics (OTC: HDYN) is an independent oil and gas exploration company engaged in the acquisition, exploration and development of oil and natural gas properties in the Republic of Guinea, Northwest Africa. The company owns a 100% interest in a concession that covers an area of approximately 7,238 square miles in offshore Guinea. Hyperdynamics was founded in 1983 and is headquartered in Houston, Texas. For more information, visit the company's website at www.hyperdynamics.com.
MassRoots (MSRT)

MassRoots (OTC: MSRT) operates a technology platform for the cannabis community in the United States. The company's mobile network enables users to share cannabis content to connect with the legalization movement. Its network is accessible as a free mobile application through the iOS App Store and the Google Play marketplace. The company also operates MassRoots.com/shop, an e-commerce platform that allows visitors to order MassRoots T-shirts, jars and stickers, as well as MassRoots for Business, a free online portal for dispensaries to schedule posts, view analytics and gain insights into followers. For more information, visit the company's website at www.massroots.com.
Microbot Medical (MBOT)

Microbot Medical (NASDAQ: MBOT) is a medical device company, engaging in the research, design, development and commercialization of micro-robotics medical technologies. The company's ViRob and TipCAT platforms consist of micro-robotic technologies, from which the company is developing its product candidates, including the Self-Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH); and a self-propelling, semi-disposable endoscope that is being developed initially for use in colonoscopy procedures. The company was founded in 2010 and is based in Yokneam, Israel. For more information, visit the company's website at www.microbotmedical.com.
NV5 Global (NVEE)

NV5 Global (NASDAQ: NVEE) provides professional and technical engineering, and consulting solutions to public and private sector clients in the infrastructure, energy, construction, real estate and environmental markets in the United States. The company offers infrastructure, engineering and support services, including site selection, design and construction and program management in water resources, transportation, structural engineering, land development, surveying, commissioning, energy performance, power delivery and other service areas; and construction quality assurance services, such as construction materials testing and engineering, geotechnical engineering and consulting, and forensic consulting. For more information, visit the company's website at www.nv5.com.
4:00 pm
Creative Realities (CREX)

Creative Realities (OTC: CREX) provides digital marketing technology solutions to retailers, brand marketers, venue-operators, enterprises, non-profits and other organizations in the United States and internationally. Its technology and solutions include digital merchandising systems, interactive digital shopping assistants and kiosks, mobile digital marketing platforms, digital way-finding platforms, digital menu board systems, dynamic signage, and other digital marketing technologies. The company enables its client to engage with consumers via technology and solutions that interact with mobile, social media, point-of-sale, wireless networks, and web-based platforms. The company sells its solutions to the hospitality, branded retail, automotive, food service, and retail healthcare industries. For more information, visit the company's website at www.cri.com.
CV Sciences (CVSI)

CV Sciences (OTC: CVSI) focuses on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol (CBD). The company operates through two segments, Specialty Pharmaceutical and Consumer Product. It also manufactures, markets and sells plant-based CBD products under PlusCBD brand for a range of market sectors, including nutraceutical, beauty care, specialty foods and vape. The company's Pharmaceutical Division is developing synthetically formulated cannabidiol‐based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. CV Sciences has achieved promising preclinical results in the development of cannabinoid medicines for treatment of a range of medical conditions. For more information, visit the company's website at www.cvsciences.com.
Finjan Holdings (FNJN)

Finjan Holdings (NASDAQ: FNJN) operates as a cybersecurity company and provider of intellectual property licensing and enforcement services. The company owns a portfolio of patents related to software and hardware technologies that proactively detect malicious code and thereby protects end-users from identity and data theft, spyware, malware, phishing, Trojans, and other web and network threats. Finjan's patented technologies are used in specific technology areas, including endpoint/cloud software, web gateway/Internet infrastructure, and networking equipment markets. The company's technology scans and repels the latest and unknown threats to network, web, and endpoint devices on a real-time basis. For more information, visit the co"

[Popeye82]

www.redchip.com/events/11/january-2017-global-online-growth-…

[Popeye82]

A - E



" 22nd Century Group, Inc. (XXII)
Abeona Therapeutics, Inc. (ABEO)
AcelRx Pharmaceuticals, Inc. (ACRX)
Acme United Corp. (ACU)
Actinium Pharmaceuticals, Inc. (ATNM)
Adamis Pharmaceuticals Corp. (ADMP)
Adesto Technologies Corp. (IOTS)
Adocia SA (ADOCF)
Aduro BioTech, Inc. (ADRO)
Advanced Emissions Solutions, Inc. (ADES)
Adverum Biotechnologies, Inc. (ADVM)
Aegion Corp. (AEGN)
Aerie Pharmaceuticals, Inc. (AERI)
Aethlon Medical, Inc. (AEMD)
Agile Therapeutics, Inc. (AGRX)
Akari Therapeutics Plc (AKTX)
Akoustis Technologies, Inc. (AKTS)
Alcobra Ltd. (ADHD)
Align Technology, Inc. (ALGN)
Alimera Sciences, Inc. (ALIM)
Ameresco, Inc. (AMRC)
American Outdoor Brands Corp. (AOBC)
American States Water Co. (AWR)
American Superconductor Corp. (AMSC)
American Vanguard Corp. (AVD)
AmpliPhi Biosciences Corp. (APHB)
Amtech Systems, Inc. (ASYS)
Amyris, Inc. (AMRS)
Apollo Endosurgery, Inc. (APEN)
Applied Genetic Technologies Corp. (AGTC)
Aptevo Therapeutics, Inc. (APVO)
Aptose Biosciences, Inc. (APTO)
Aqua Metals, Inc. (AQMS)
Arch Therapeutics, Inc. (ARTH)
ARI Network Services, Inc. (ARIS)
Aspen Group, Inc. (ASPU)
Asure Software, Inc. (ASUR)
ATN International, Inc. (ATNI)
Attunity, Ltd. (ATTU)
Auris Medical Holding AG (EARS)
Auxilio, Inc. (AUXO)
Avadel Pharmaceuticals Plc (AVDL)
AVEO Oncology (AVEO)
Aviat Networks, Inc. (AVNW)
Avino Silver & Gold Mines Ltd. (NSYE: ASM)
AxoGen, Inc. (AXGN)
Azure Power Global Ltd. (AZRE)
Ballard Power Systems, Inc. (BLDP)
Barfresh Food Group, Inc. (BRFH)



Barrett Business Services, Inc. (BBSI)
Bel Fuse, Inc. (BELFB)
BG Staffing, Inc. (BGSF)
BioAmber, Inc. (BIOA)
Biocept, Inc. (BIOC)
BioDelivery Sciences International, Inc. (BDSI)
BIOLASE, Inc. (BIOL)
BioLineRx, Ltd. (BLRX)
Biomerica, Inc. (BMRA)
Bionomics Ltd (BNOEF)
BioPharmX Corp. (BPMX)
BioSig Technologies, Inc. (BSGM)
BioSpecifics Technologies (BSTC)
Blue Bird Corp. (BLBD)
BNK Petroleum, Inc. (BNKPF)
Bovie Medical Corp. (BVX)
Broadwind Energy, Inc. (BWEN)
Cachet Financial Solutions, Inc. (CAFN)
Cadiz, Inc. (CDZI)
Caladrius Biosciences, Inc. (CLBS)
Calgon Carbon Corp. (CCC)
Callaway Golf Co. (ELY)
Callidus Software, Inc. (CALD)
Camber Energy, Inc. (CEI)
Capricor Therapeutics, Inc. (CAPR)
Capstone Companies, Inc. (CAPC)
Capstone Turbine Corp. (CPST)
CAS Medical Systems, Inc. (CASM)
Castle Brands, Inc. (ROX)
Catalyst Pharmaceuticals, Inc. (CPRX)
Catasys, Inc. (OTC: CATS)
Cavium, Inc. (CAVM)
CECO Environmental Corp. (CECE)
Cellectar Biosciences, Inc. (CLRB)
Cellectis SA (CLLS)
Cempra, Inc. (CEMP)
Cemtrex, Inc. (CETX)
CEVA, Inc. (CEVA)
Charles & Colvard Ltd. (CTHR)
Check-Cap Ltd. (CHEK)
Checkpoint Therapeutics, Inc. (CKPT)
Cherokee, Inc. (CHKE)
Clean Diesel Technologies, Inc. (CDTI)
Clearfield, Inc. (CLFD)
Coeur Mining, Inc. (CDE)
Cogentix Medical, Inc. (CGNT)
Columbus McKinnon Corp. (CMCO)
Command Center, Inc. (CCNI)
Compass Diversified Holdings LLC (CODI)



Conatus Pharmaceuticals, Inc. (CNAT)
Concert Pharmaceuticals, Inc. (CNCE)
Connection, Inc. (CNXN)
Consolidated Water Co. Ltd. (CWCO)
Contango Oil & Gas Co. (MCF)
Cooper-Standard Holdings, Inc. (CPS)
COPsync, Inc. (COYN)
Craft Brew Alliance, Inc. (BREW)
Crius Energy Trust (CRIUF)
Crown Crafts, Inc. (CRWS)
Cryoport, Inc. (CYRX)
CTI BioPharma Corp. (CTIC)
CTS Corp. (CTS)
Cutera, Inc. (CUTR)
CymaBay Therapeutics, Inc. (CBAY)
Cytokinetics, Inc. (CYTK)
Cytori Therapeutics, Inc. (CYTX)
CytRx Corp. (CYTR)
Daqo New Energy Corp. (DQ)
Darling Ingredients, Inc. (DAR)
Data I/O Corp. (DAIO)
Delcath Systems, Inc. (DCTH)
Delta Apparel, Inc. (DLA)
Denison Mines Corp. (DNN)
Denny's Corp. (DENN)
Depomed, Inc. (DEPO)
Diamcor Mining Inc. (DMIFF)
Diamondback Energy, Inc. (FANG)
Differential Brands Group, Inc. (DFBG)
Digirad Corp. (DRAD)
Digital Turbine, Inc. (APPS)
Diodes, Inc. (DIOD)
Diversified Restaurant Holdings, Inc. (SAUC)
DLH Holdings Corp. (DLHC)
DMC Global, Inc. (BOOM)
Dolphin Digital Media, Inc. (DPDM)
DSP Group, Inc. (DSPG)
Ducommun, Inc. (DCO)
Dynatronics Corp. (DYNT)
Earthstone Energy, Inc. (ESTE)
Eastside Distilling, Inc. (ESDI)
Eiger Biopharmaceuticals (EIGR)
Ekso Bionics Holdings, Inc. (EKSO)
Electrovaya, Inc. (EFLVF)
Eleven Biotherapeutics, Inc. (EBIO)
Elio Motors, Inc. (ELIO)
Ellie Mae, Inc. (ELLI)
EMCORE Corp. (EMKR)
Emefcy Group Ltd. (EMFGF)
http://conferences.networknewswire.net/2017/roth/ "

[Popeye82]

Antwort auf Beitrag Nr.: 54.522.731 von Popeye82 am 13.03.17 01:02:21

F - J



" FORM Holdings Corp. (FH)
Fortress Biotech, Inc. (FBIO)
Franklin Covey Co. (FC)
Frankly, Inc. (FLKKF)
FuelCell Energy, Inc. (FCEL)
Gaia, Inc. (GAIA)
Galectin Therapeutics, Inc. (GALT)
GEE Group, Inc. (JOB)
Gentherm, Inc. (THRM)
Glaukos Corp. (GKOS)
Global Blood Therapeutics, Inc. (GBT)
Global Self Storage, Inc. (SELF)
Global Water Resources, Inc. (GWRS)
Glu Mobile, Inc. (GLUU)
Goodrich Petroleum Corp. (GDPP)
GP Strategies Corp. (GPX)
Green Plains, Inc. (GPRE)
GSE Systems, Inc. (GVP)
Guidance Software, Inc. (GUID)
GWG Holdings, Inc. (GWGH)
H2O Innovation, Inc. (HEOFF)
Halcon Resources Corp. (HK)



Hannon Armstrong Sustainable
Infrastructure Capital, Inc. (HASI)
Hanwha Q CELLS Co., Ltd. (HQCL)
Heat Biologics, Inc. (HTBX)
Heritage-Crystal Clean, Inc. (HCCI)
Highpower International, Inc. (HPJ)
Himax Technologies, Inc. (HIMX)
Horizon Global Corp. (HZN)
Hortonworks, Inc. (HDP)
Hudson Technologies, Inc. (HDSN)
Hydrogenics Corp. (HYGS)
iCAD, Inc. (ICAD)
Iconix Brand Group, Inc. (ICON)
ICU Medical, Inc. (ICUI)
ID Systems, Inc. (IDSY)
Ideal Power, Inc. (IPWR)
IEC Electronics Corp. (IEC)
ImageWare Systems, Inc. (IWSY)
IMAX Corp. (IMAX)
InMed Pharmaceuticals, Inc. (IMLFF)
Innovative Industrial Properties, Inc. (IIPR)
Inotek Pharmaceuticals Corp. (ITEK)



Inphi Corp. (IPHI)
Inseego Corp. (INSG)
Insperity, Inc. (NSP)
Intec Pharma Ltd. (NTEC)
Intevac, Inc. (IVAC)
Intellipharmaceutics International, Inc. (IPCI)
Inventure Foods, Inc. (SNAK)
Inuvo, Inc. (INUV)
iPass, Inc. (IPAS)
IRadimed Corp. (IRMD)
IRIDEX Corp. (IRIX)
Ironclad Performance Wear Corp. (ICPW)
Issuer Direct Corp. (ISDR)
Iteris, Inc. (ITI)
ITM Power Plc (ITMPF)
IZEA, Inc. (IZEA)
JA Solar Holdings Co., Ltd. (JASO)
Jaguar Animal Health, Inc. (JAGX)
JetPay Corp. (JTPY)
JinkoSolar Holding Co., Ltd. (JKS)
Juniper Pharmaceuticals, Inc. (JNP)
http://conferences.networknewswire.net/2017/roth/f-j.php "

[Popeye82]

Antwort auf Beitrag Nr.: 54.522.761 von Popeye82 am 13.03.17 01:49:45

K - O



" KemPharm (KMPH)
Kite Pharma (KITE)
Knowles Corp. (KN)
Kona Grill, Inc. (KONA)
Kopin Corp. (KOPN)
Kratos Defense & Security Solutions, Inc. (KTOS)
Lakeland Industries, Inc. (LAKE)
Landec Corp. (LNDC)
Lannett Company, Inc. (LCI)
Leaf Group (LFGR)
LeMaitre Vascular, Inc. (LMAT)
Ligand Pharmaceuticals, Inc. (LGND)
LightPath Technologies, Inc. (LPTH)
Limbach Holdings, Inc. (LMB)
Limoneira Company (LMNR)
Lion Biotechnologies, Inc. (LBIO)
Lipocine, Inc. (LPCN)
LivePerson, Inc. (LPSN)
LM Funding America, Inc. (LMFA)
Lonestar Resources US, Inc. (LONE)
LRAD Corp. (LRAD)
Lumenpulse, Inc. (LMPLF)
Lydall, Inc. (LDL)
MacroGenics, Inc. (MGNX)
Madrigal Pharmaceuticals, Inc. (MDGL)
MAG Silver Corp. (MAG)
Magal Security Systems Ltd. (MAGS)
Manitex International, Inc. (MNTX)



MannKind Corp. (MNKD)
Marathon Patent Group, Inc. (MARA)
Marchex, Inc. (MCHX)
Marina Biotech, Inc. (MRNA)
Masimo Corp. (MASI)
MassRoots, Inc. (MSRT)
Mast Therapeutics, Inc. (MSTX)
Mateon Therapeutics, Inc. (MATN)
Matinas BioPharma Holdings, Inc. (MTNB)
Mattersight Corp. (MATR)
MaxLinear, Inc. (MXL)
Maxwell Technologies, Inc. (MXWL)
Mellanox Technologies, Ltd. (MLNX)
Mesoblast Ltd. (MESO)
Microbot Medical, Inc. (MBOT)
Microsemi Corp. (MSCC)
Middleby Corp. (MIDD)
Midstates Petroleum Company (MPO)
Midwest Energy Emissions Corp. (MEEC)
MINDBODY, Inc. (MB)
Mitek Systems, Inc. (MITK)
Model N, Inc. (MODN)
Mogo Finance Technology, Inc. (MFTGF)
Moleculin Biotech Inc. (MBRX)
Monaker Group, Inc. (MKGI)
Motorcar Parts of America, Inc. (MPAA)
Naked Brand Group (NAKD)
Nano Dimension Ltd. (NNDM)



NantKwest (NK)
Natus Medical, Inc. (BABY)
Nemaska Lithium, Inc. (NMKEF)
Nemus Bioscience, Inc. (NMUS)
Neogen Corp. (NEOG)
Neogenomics, Inc. (NEO)
Neptune Technologies & Bioresources, Inc. (NEPT)
NeuroDerm Ltd. (NDRM)
New Age Beverages (NBEV)
Nouveau Monde Graphite (NMGRF)
NovaBay Pharmaceuticals, Inc. (NBY)
Novelion Therapeutics, Inc. (NVLN)
Novogen (NVGN)
NTN Buzztime, Inc. (NTN)
Nuvectra Corp. (NVTR)
NV5 Global, Inc. (NVEE)
Ocean Power Technologies, Inc. (OPTT)
Oclaro, Inc. (OCLR)
On Assignment, Inc. (ASGN)
Onconova Therapeutics, Inc. (ONTX)
OptimizeRx Corp. (OPRX)
Organovo (ONVO)
Origin Agritech Ltd. (SEED)
Orion Energy Systems, Inc. (OESX)
Ormat Technologies, Inc. (ORA)
OSI Systems, Inc. (OSIS)
OTC Markets Group, Inc. (OTCM)
http://conferences.networknewswire.net/2017/roth/k-o.php "

[Popeye82]

Antwort auf Beitrag Nr.: 54.522.767 von Popeye82 am 13.03.17 02:09:19

P - T



" Pacific Ethanol, Inc. (PEIX)
Palatin Technologies, Inc. (PTN)
Pandora Media, Inc. (P)
PAR Technology Corp. (PAR)
Paramount Gold Nevada Corp. (PZG)
PCM, Inc. (PCMI)
PDL BioPharma Inc. (PDLI)
Peregrine Pharmaceuticals, Inc. (PPHM)
Perma-Fix Environmental Services, Inc. (PESI)
Pershing Gold Corp. (PGLC)
PetroQuest Energy, Inc. (PQ)
PhaseRx, Inc. (PZRX)
Pieris Pharmaceuticals, Inc. (PIRS)
Pioneer Power Solutions, Inc. (PPSI)
Pixelworks, Inc. (PXLW)
Planet Fitness, Inc. (PLNT)
Platform Specialty Products Corporation (PAH)
Pointer Telocation Ltd (PNTR)
Polar Power Inc. (POLA)
Pretium Resources Inc. (PVG)
Primo Water Corporation (PRMW)
Pro-Dex Inc. (PDEX)
Professional Diversity Net, Inc. (IPDN)
Profire Energy, Inc. (PFIE)
PURE Bioscience, Inc. (PURE)
Pyxis Tankers Inc. (PXS)
Quantenna Communications, Inc. (QTNA)
Quantum Corp. (QTM)
Quest Resource Holding Corp. (QRHC)



QuickLogic Corp. (QUIK)
RADA Electronic Ind. Ltd. (RADA)
RadiSys Corporation (RSYS)
Rambus Inc. (RMBS)
Recro Pharma, Inc. (REPH)
REEDS, Inc. (REED)
Regulus Therapeutics Inc. (RGLS)
Reis, Inc. (REIS)
Remark Media, Inc. (MARK)
Renewable Energy Group, Inc. (REGI)
Resaas Services, Inc. (RSASF)
Research Frontiers Inc. (REFR)
Research Solutions Inc. (RSSS)
Resonant Inc. (RESN)
Revolution Lighting Technologies, Inc. (RVLT)
Sorrento Therapeutics, Inc. (SRNE)
Spartan Motors, Inc. (SPAR)
Spotlight Innovation, Inc. (STLT)
Stamps.com, Inc. (STMP)
StarTek, Inc. (SRT)
Stemline Therapeutics, Inc. (STML)
Strongbridge Biopharma (SBBP)
Sucampo Pharmaceuticals, Inc. (SCMP)
Summer Infant, Inc. (SUMR)
Sunworks, Inc. (SUNW)
Super Micro Computer, Inc. (SMCI)
Superior Drilling Products, Inc. (SDPI)
Syndax Pharmaceuticals, Inc. (SNDX)
Synthetic Biologics Inc. (SYN)



TAG Oil Ltd (TAOIF)
Tandem Diabetes Care, Inc. (TNDM)
Tandy Leather Factory (TLF)
TearLab Corp. (TEAR)
Tecogen Inc. (TGEN)
Teligent, Inc. (TLGT)
Telit Communications PLC (TTCNF)
Tetra Tech, Inc. (TTEK)
Tetraphase Pharmaceuticals, Inc. (TTPH)
TG Therapeutics, Inc. (TGTX)
The Hackett Group, Inc. (HCKT)
The Joint Corp. (JYNT)
The Ultimate Software Group, Inc. (ULTI)
TheStreet, Inc. (TST)
Tilly's, Inc. (TLYS)
Titan Medical, Inc. (TMD)
Titan Pharmaceuticals, Inc. (TTNP)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Top Image Systems Ltd. (TISA)
Tower Semiconductor Ltd. (TSEM)
TPI Composites, Inc. (TPIC)
TRACON Pharmaceuticals, Inc. (TCON)
TransAct Technologies, Inc. (TACT)
Transcat, Inc. (TRNS)
Trecora Resources (TREC)
TriMas Corp. (TRS)
TrovaGene, Inc. (TROV)
Trupanion, Inc. (TRUP)
Turtle Beach Corp. (HEAR)
http://conferences.networknewswire.net/2017/roth/p-t.php "

[Popeye82]

Antwort auf Beitrag Nr.: 54.525.452 von Popeye82 am 13.03.17 13:22:52

U - Z



" U.S. Auto Parts Network, Inc. (PRTS)
U.S. Geothermal, Inc. (HTM)
UniPixel, Inc. (UNXL)
Unique Fabricating, Inc. (UFAB)
Uniroyal Global Engineered Products (UNIR)
Upland Software, Inc. (UPLD)
Uranium Resources, Inc. (URRE)
UR-Energy, Inc. (URG)
US Energy Corp. (USEG)
USA Technologies, Inc. (USAT)
Vaalco Energy, Inc. (EGY)
Valeritas, Inc. (VLRX)
Vascular Biogenics Ltd. (VBLT)



Veloxis Pharmaceuticals (VELO)
Verastem, Inc. (VSTM)
Vericel Corp. (VCEL)
Vertex Energy, Inc. (VTNR)
Veru Healthcare (FHCO)
Viking Therapeutics, Inc. (VKTX)
Viper Energy Partners (VNOM)
Vista Outdoor, Inc. (VSTO)
VivoPower International PLC (VVPR)
VolitionRX Ltd (VNRX)
Volt Information Sciences, Inc. (VISI)
vTv Therapeutics, Inc. (VTVT)
W&T Offshore, Inc. (WTI)



Web.com Group, Inc. (WEB)
Wilhelmina International, Inc. (WHLM)
Willdan Group, Inc. (WLDN)
Workiva, Inc. (WK)
Xenetic Biosciences, Inc. (XBIO)
XO Group, Inc. (XOXO)
Xplore Technologies Corp. (XPLR)
Yield10 Bioscience (YTEN)
Yuma Energy, Inc. (YUMA)
Zafgen, Inc. (ZFGN)
Zix Corporation (ZIXI)
Zosano Pharma Corp. (ZSAN)
Zynerba Pharmaceuticals, Inc. (ZYNE)
http://conferences.networknewswire.net/2017/roth/u-z.php "

[Popeye82]

Antwort auf Beitrag Nr.: 54.527.837 von Popeye82 am 13.03.17 18:48:00

theEND

[Popeye82]

MeetMax



www.meetmax.com/sched/event_39822/~public/conference_compani…

Eine im depot:

"1347 Property Insurance Holdings, Inc. (NASDAQ: PIH)
Alternate Health Corp. (CSE: AHG) (OTCQB: AHGIF)
AmpliTech Group, Inc. (OTCQB: AMPG)
ARCA biopharma, Inc. (NASDAQ: ABIO)
Arcadia Integrated Companies Inc. (Private Company)
Bee Vectoring Technologies (TSX-V: BEE)
Biomerica, Inc. (NASDAQ: BMRA)
Canarc Resource Corp. (TSX: CCM) (OTCBB: CRCUF)
Cardiff International, Inc. (OTCQB: CDIF)
Century Casinos, Inc. (NASDAQ: CNTY)
Clarocity Corporation (TSX-V: CLY)
Drone USA, Inc. (OTC Pink: DRUS)
Endexx Corporation (OTC Pink: EDXC)
EnWave Corporation (TSX-V: ENW)
FISION Corporation (OTCQB: FSSN)
Galaxy Gaming, Inc. (OTCQB: GLXZ)
Gatekeeper Systems Inc. (TSX-V: GSI) (OTC: GKPRF)
Genie Energy Ltd. (NYSE: GNE)
Golden Predator Mining Corp. (TSX-V: GPY) (OTCQX: NTGSF)
Graphite One Resources Inc. (TSX-V: GPH) (OTCQB: GPHOF)
Green EnviroTech Holdings Corp. (OTC Pink: GETH)
Ironclad Performance Wear Corp. (OTCQB: ICPW)
IsoRay, Inc. (NYSE MKT: ISR)
Jericho Oil Corporation (TSX-V: JCO) (OTC: JROOF)
Mace Security International Inc. (OTCQX: MACE)
Manhattan Bridge Capital, Inc. (NASDAQ: LOAN)
Marapharm Ventures Inc. (CSE: MDM) (OTCQB: MRPHF)
Meridian Waste Solutions, Inc. (NASDAQ: MRDN)
NanoViricides, Inc. (NYSE MKT: NNVC)
Newtek Business Services Corp. (NASDAQ: NEWT)
OMNOVA Solutions Inc. (NYSE: OMN)
Orion Energy Systems, Inc. (NASDAQ: OESX)
Pressure BioSciences, Inc. (OTCQB: PBIO)
Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT)
RCI Hospitality Holdings, Inc. (NASDAQ: RICK)
Reign Sapphire Corporation (OTCQB: RGNP)
RIWI Corporation (CSE: RIW)
SRAX, Inc. (NASDAQ: SRAX)
Tarku Resources Ltd. (TSX-V: TKU)
The Chron Organization, Inc. (OTC Pink: CHRO)
The Singing Machine Company (OTCQX: SMDM)
Thorn Energy Corp. (Private Company)
True Leaf Medicine International Ltd. (CSE: MJ)
UGE International Ltd. (TSX-V: UGE)
Uranium Resources, Inc. (NASDAQ: URRE)
US Nuclear Corp. (OTC Pink: UCLE)
Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF)
VolitionRx Ltd. (NYSE MKT: VNRX)"